ulcerative colitis: An inflammatory bowel disease involving the mucosal surface of the large intestine and rectum. It may present with an acute or slow onset and follows an intermittent or continuous course. Signs and symptoms include abdominal pain, diarrhea, fever, weight loss, and intestinal hemorrhage.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
2342 |
4. Check minimum number of eventsNone |
2342 |
5. Include endpointsNone |
2342 |
6. Filter based on genotype QC (FinnGen only) |
2342 |
Control definitions (FinnGen only)
- Control exclude
- K11_ENERCOLNONINF
Extra metadata
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- K51
- Name in latin
- Alia colitis ulcerosa specificata
Similar endpoints
↥List of similar endpoints to
Other ulcerative colitis
based on the number of shared cases.
Similar with more cases:
- Ulcerative colitis
- Inflammatory bowel disease
- Noninfective enteritis and colitis
- Autoimmune diseases related-to ILD
- Autoimmune diseases
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 12782 | 6042 | 6700 |
| Only index persons | 12237 | 5850 | 6387 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.18 | 0.17 | 0.19 |
| Only index persons | 0.23 | 0.22 | 0.24 |
| Median age at first event (years) | |||
| Whole population | 43.13 | 41.97 | 44.08 |
| Only index persons | 42.48 | 41.50 | 43.39 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 2342 | 1229 | 1113 |
| Unadjusted period prevalence (%) | 0.45 | 0.42 | 0.49 |
| Median age at first event (years) | 43.94 | 41.20 | 46.96 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 2114
- Matched controls
- 21138
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
K50.1
ICD-10 Finland
Crohn disease of large intestine
+∞
323.0
355
*
K51.8
ICD-10 Finland
Other ulcerative colitis
4503599627370496.0
323.0
2113
*
H02AB06
ATC
prednisolone; systemic
9.3
323.0
1689
6321
A07EC02
ATC
mesalazine; oral, rectal
1849.9
323.0
1842
77
K51.1
ICD-10 Finland
Ulcerative (chronic) ileocolitis
+∞
323.0
460
*
A07EA06
ATC
budesonide; oral, local oral
251.3
323.0
738
45
L04AX01
ATC
azathioprine; systemic
95.9
323.0
1027
206
K51.9
ICD-10 Finland
Ulcerative colitis, unspecified
6363.0
323.0
1329
6
K50.8
ICD-10 Finland
Other Crohn disease
+∞
323.0
402
*
K51.2
ICD-10 Finland
Ulcerative (chronic) proctitis
2403.9
323.0
373
*
K51.3
ICD-10 Finland
Ulcerative (chronic) rectosigmoiditis
+∞
323.0
707
*
K50.9
ICD-10 Finland
Crohn disease, unspecified
1249.5
323.0
319
*
UJF30
NOMESCO Finland
Ileoscopy through colon
21.3
323.0
858
656
UJF32
NOMESCO Finland
Coloscopy
31.3
323.0
1682
2335
A07EA02
ATC
hydrocortisone; rectal
365.4
323.0
769
33
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
14.7
323.0
622
581
K51.0
ICD-10 Finland
Ulcerative (chronic) pancolitis
+∞
323.0
396
*
K51.5
ICD-10 Finland
Left sided colitis
8596.3
323.0
1230
*
208
Kela drug reimbursment
Ulcerative colitis and Crohn's disease
+∞
323.0
1891
*
A07EC01
ATC
sulfasalazine; oral, rectal
12.1
306.6
609
686
K51
ICD-10 Finland
Ulcerative colitis
1696.5
305.7
290
*
K52.9
ICD-10 Finland
Noninfective gastroenteritis and colitis, unspecified
53.6
292.4
350
78
UJF14
NOMESCO Finland
Enteroscopy of ileoanal anastomosis
738.0
269.2
260
*
H02AB07
ATC
prednisone; oral
7.1
244.5
691
1348
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
5.2
243.4
1001
3105
L01BB02
ATC
mercaptopurine; oral
231.7
242.3
246
12
326
Kela drug reimbursment
Adalimumab, golimumab, infliximab and ustekinumab (intestinal diseases)
+∞
240.3
226
*
K50.0
ICD-10 Finland
Crohn disease of small intestine
2104.5
212.0
202
*
J01MA02
ATC
ciprofloxacin; systemic
4.2
201.7
1161
4771
K52.88
ICD-10 Finland
Other specified noninfective gastroenteritis and colitis
125.8
201.5
215
19
D94
ICPC
Chronic enteritis/ulcerative colitis
286.1
181.8
183
7
A07EA01
ATC
prednisolone; rectal
464.7
174.5
172
*
P01AB01
ATC
metronidazole; oral, rectal
3.7
168.5
1164
5300
UJF12
NOMESCO Finland
Enteroscopy through intestinal stoma
+∞
166.9
158
*
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
4.0
159.9
848
3057
ZX120
NOMESCO Finland
Intravenous
6.5
154.9
445
829
56310
ICD-8 Finland
Chronic enteritis and ulcerative colitis, Ulcerative colitis
+∞
141.2
134
*
M07.5*K51.9
ICD-10 Finland
Arthropathy in ulcerative colitis
+∞
130.6
124
*
JFH30
NOMESCO Finland
Total colectomy, mucosal proctectomy and ileoanal anastomosis without ileostomy
+∞
128.5
122
*
K83.0
ICD-10 Finland
Cholangitis
32.1
126.7
169
57
TPH04
NOMESCO Finland
Cathetrisation of vein
3.8
125.1
656
2248
5561A
ICD-9 Finland
Idiopathic proctocolitis, Ulcerative (chronic) ileocolitis
+∞
124.2
118
*
O99.6
ICD-10 Finland
Diseases of the digestive system complicating pregnancy, childbirth and the puerperium
71.8
123.4
141
21
5562A
ICD-9 Finland
Idiopathic proctocolitis, Ulcerative (chronic) proctitis
+∞
119.9
114
*
5568X
ICD-9 Finland
Idiopathic proctocolitis, Other ulcerative colitis
+∞
99.8
95
*
A05AA02
ATC
ursodeoxycholic acid; oral
16.3
98.6
163
108
L04AB04
ATC
adalimumab; parenteral
13.9
91.1
161
125
JFG00
NOMESCO Finland
Closure of loop enterostomy without resection
53.6
89.5
107
21
UJF92
NOMESCO Finland
Capsular endoscopy
14.0
86.6
152
116
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
3.2
86.3
533
1988
A06AC01
ATC
ispaghula (psylla seeds); oral
3.0
82.1
582
2378
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
10.6
78.7
158
160
A07DA03
ATC
loperamide; oral
8.6
76.6
174
219
WX302
NOMESCO Finland
Thoracal epidural anesthesy
6.2
73.1
208
364
A07EC03
ATC
olsalazine; oral
711.2
70.5
69
*
Z93.2
ICD-10 Finland
Ileostomy status
129.5
70.4
75
6
JKE98
NOMESCO Finland
Other transduodenal endoscopic operation on bile duct or ampulla of Vater
16.4
70.2
115
74
JFH10
NOMESCO Finland
Total colectomy and ileostomy
151.1
69.4
73
5
4AA12
NOMESCO Finland
NA
149.0
68.4
72
5
4AB02
NOMESCO Finland
NA
124.2
67.3
72
6
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.3
67.1
929
5390
JF1CG
NOMESCO Finland
Extensive MRI of small bowel
46.7
66.3
81
18
C10AC01
ATC
colestyramine; oral
10.8
66.1
131
129
A02BC02
ATC
pantoprazole; systemic
2.2
60.8
1365
9677
JFH33
NOMESCO Finland
Total colectomy, mucosal proctectomy, ileoanal anastomosis and ileostomy
604.7
60.0
59
*
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
3.7
58.2
283
855
H02AB09
ATC
hydrocortisone; systemic
9.0
56.4
123
144
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
3.3
56.4
320
1090
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
5.7
56.2
170
319
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
4.7
55.4
202
467
WX002
NOMESCO Finland
Sedation and analgesia
2.6
54.8
470
2086
JN3BD
NOMESCO Finland
Extensive abdominal CT
3.3
53.1
305
1042
L04AD01
ATC
ciclosporin; systemic
9.2
52.6
113
129
K50
ICD-10 Finland
Crohn disease [regional enteritis]
266.9
51.3
52
*
JFF10
NOMESCO Finland
Loop enterostomy
29.2
50.3
68
24
K92.1
ICD-10 Finland
Melaena
5.4
50.0
157
308
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
3.4
49.2
267
874
JGB50
NOMESCO Finland
Mucosal proctectomy and ileoanal anastomosis
+∞
48.1
46
*
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
7.3
46.4
115
165
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
10.0
46.0
94
98
L04AC05
ATC
ustekinumab; parenteral
85.4
45.0
50
6
JFH20
NOMESCO Finland
Proctocolectomy and ileostomy
+∞
43.9
42
*
K56.5
ICD-10 Finland
Intestinal adhesions [bands] with obstruction
10.4
43.6
87
87
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.0
43.0
793
4923
JFH11
NOMESCO Finland
Laparoscopic colectomy
+∞
42.8
41
*
UJG02
NOMESCO Finland
Proctoscopy
8.7
42.2
93
111
M07.5
ICD-10 Finland
Arthropathy in ulcerative colitis
+∞
41.8
40
*
1370
FHL
Colonoscopy, whole colon
40.2
40.7
51
13
JL5SB
NOMESCO Finland
Endoscopic retrograd cholangiopancreaticography
11.1
38.5
74
69
JF1DG
NOMESCO Finland
Small bowel very extensive MRI with with high intensity magnet
46.9
37.9
46
10
4AA33
NOMESCO Finland
NA
+∞
37.6
36
*
L04AA01
ATC
[U] ciclosporin; systemic
9.6
37.6
78
84
JF1BD
NOMESCO Finland
Very extensive small bowel CT
25.3
37.2
52
21
JFA15
NOMESCO Finland
Endoscopic polypectomy in colon
4.2
36.3
144
360
JAH00
NOMESCO Finland
Laparotomy
6.6
35.8
94
147
JFG20
NOMESCO Finland
Closure of enterostomy with resection of exteriorised loop
32.0
35.8
47
15
UJK02
NOMESCO Finland
ERCP
7.0
35.7
90
133
N02AX02
ATC
tramadol; systemic, rectal
1.8
35.5
837
5572
Z01.8
ICD-10 Finland
Other specified special examinations
2.1
35.3
476
2568
JL5BG
NOMESCO Finland
MRI examinaiton of bile and pancreas ducts with high intesity magnet
6.8
35.2
91
139
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
6.2
35.2
97
162
A07AA09
ATC
vancomycin; oral
13.3
34.7
61
47
3042
Kela drug reimbursment
NA
+∞
34.5
33
*
253
Kela drug reimbursment
NA
+∞
34.5
33
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.4
34.4
317
1430
K56.7
ICD-10 Finland
Ileus, unspecified
10.0
34.1
69
71
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
7.5
34.1
82
113
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
4.7
33.9
120
268
6419
FHL
Other measure in this category
177.8
33.8
35
*
L04AB06
ATC
golimumab; parenteral
11.6
33.6
63
56
K51.4
ICD-10 Finland
Inflammatory polyps
+∞
33.4
32
*
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
3.2
33.2
184
607
A02BC01
ATC
omeprazole; systemic
2.0
32.7
544
3177
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
3.7
32.3
147
415
Z93
ICD-10 Finland
Artificial opening status
62.7
32.1
37
6
JFF13
NOMESCO Finland
Terminal enterostomy
53.7
31.3
37
7
M07.4*K50.9
ICD-10 Finland
Arthropathy in Crohn's disease [regional enteritis]
+∞
31.3
30
*
JFG73
NOMESCO Finland
Excision of ileal pelvic pouch
+∞
31.3
30
*
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.6
30.3
246
1033
JH1CG
NOMESCO Finland
Extensive MRI of perianal area
18.8
30.1
46
25
UJK12
NOMESCO Finland
Peroral cholangioscopy
69.0
29.9
34
5
A02BC03
ATC
lansoprazole; oral
1.9
29.9
568
3463
JHA00
NOMESCO Finland
Anal or perianal incision
7.7
29.9
70
93
K59.1
ICD-10 Finland
Functional diarrhoea
3.9
29.6
127
341
L01BA01
ATC
methotrexate; systemic (folic acid analog.)
4.4
29.3
110
261
C05AA08
ATC
fluocortolone; rectal, topical
2.3
29.3
308
1475
B01AB05
ATC
enoxaparin; parenteral
1.9
28.5
560
3446
JFG40
NOMESCO Finland
Revision of enterostomy or colostomy without laparotomy
36.6
28.4
36
10
5560A
ICD-9 Finland
Idiopathic proctocolitis, Ulcerative (chronic) enterocolitis
+∞
28.2
27
*
N02BE01
ATC
paracetamol; systemic, rectal
1.8
28.2
1722
14876
R50.9
ICD-10 Finland
Fever, unspecified
2.2
28.0
317
1567
JN3AD
NOMESCO Finland
Abdominal CT examination
2.9
27.5
182
676
3AC01
NOMESCO Finland
NA
8.8
27.3
59
69
K62.8
ICD-10 Finland
Other specified diseases of anus and rectum
11.3
27.1
51
46
JFB00
NOMESCO Finland
Partial resection of small intestine
8.5
26.8
59
71
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
5.1
26.7
86
174
J01MA12
ATC
levofloxacin; systemic
2.0
26.1
360
1933
TJF80
NOMESCO Finland
Ostomy education
9.7
26.0
53
56
K52.80
ICD-10 Finland
(Hemorrhagic) colitis caused by antibiotics
263.7
25.7
26
*
R19.8
ICD-10 Finland
Other specified symptoms and signs involving the digestive system and abdomen
7.8
25.3
59
78
WX402
NOMESCO Finland
General anaesthesia
2.0
25.0
365
2002
WVA20
NOMESCO Finland
Medicine administration
5.4
24.9
76
145
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
8.3
24.7
55
68
M45
ICD-10 Finland
Ankylosing spondylitis
5.0
24.6
80
164
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
2.2
24.6
264
1272
601
Kela drug reimbursment
Severe malabsorption of nutrients, mainly fats
11.8
24.5
45
39
JL5AG
NOMESCO Finland
Simple MRI examinaiton of bile and pancreas ducts with high intesity magnet
11.2
24.4
46
42
UJF02
NOMESCO Finland
Peroral enteroscopy
18.8
24.4
37
20
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.6
24.3
191
785
M09.2*K51.9
ICD-10 Finland
Juvenile arthritis in ulcerative colitis
+∞
24.0
23
*
SPAT1263
SPAT
Sampling
1.6
23.6
837
6070
K61.0
ICD-10 Finland
Anal abscess
5.5
23.5
70
130
H02AB04
ATC
methylprednisolone; systemic
2.1
23.4
294
1517
SPAT1262
SPAT
Handing over of treatment supplies
2.0
22.9
344
1900
K60.3
ICD-10 Finland
Anal fistula
4.9
22.9
76
160
JFA98
NOMESCO Finland
Other transluminal endoscopic local operation on intestine
6.3
22.8
61
99
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
3.0
22.8
138
484
M05BA04
ATC
alendronic acid; oral
3.0
22.8
136
472
K91.4
ICD-10 Finland
Colostomy and enterostomy malfunction
40.5
22.7
28
7
3005
Kela drug reimbursment
Tofacitinib
35.4
22.1
28
8
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
2.5
21.8
182
772
1490
FHL
Sigmoideoscopy (fiberscope)
39.1
21.7
27
7
K56.0
ICD-10 Finland
Paralytic ileus
11.6
21.7
40
35
D50.0
ICD-10 Finland
Iron deficiency anaemia secondary to blood loss (chronic)
4.1
21.3
84
210
WX408
NOMESCO Finland
General anesthesy, balanced
1.7
20.8
536
3533
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
2.3
20.8
212
992
A02BC05
ATC
esomeprazole; systemic
1.6
20.6
750
5419
UJD02
NOMESCO Finland
Gastroscopy
3.3
20.2
106
337
5586X
ICD-9 Finland
Other non-infective gastro-enteritis and colitis[KROONINEN INFLAMMATOORINEN SUOLISTOSAIRAUS, NUD]
+∞
19.8
19
*
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.6
19.7
770
5648
Z98.0
ICD-10 Finland
Intestinal bypass and anastomosis status
13.3
19.7
34
26
K43.9
ICD-10 Finland
Other and unspecified ventral hernia without obstruction or gangrene
3.2
19.6
106
344
JF2AB
NOMESCO Finland
Colongraphy with X-ray
40.5
19.5
24
6
TPH07
NOMESCO Finland
Cathetrisation of artery
2.3
19.3
187
853
JJC00
NOMESCO Finland
Allogenic transplantation of liver
26.3
19.1
26
10
JHD00
NOMESCO Finland
Anal dilatation
9.9
19.1
38
39
6410
FHL
Panprococolectomy and ileostomy
+∞
18.8
18
*
JGB40
NOMESCO Finland
Excision of rectum and end ileostomy
+∞
18.8
18
*
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
2.5
18.7
156
659
UJF34
NOMESCO Finland
Left colonoscopy
10.4
18.6
36
35
Z94.4
ICD-10 Finland
Liver transplant status
16.3
18.3
29
18
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.5
18.3
143
586
JHW96
NOMESCO Finland
Other operation on anus or perianal tissue
13.7
18.2
31
23
L04AA29
ATC
tofacitinib; oral
26.9
17.8
24
9
L04AA33
ATC
vedolizumab; parenteral
+∞
17.7
17
*
1380
FHL
Colonoscopy, left side
+∞
17.7
17
*
56399
ICD-8 Finland
Chronic enteritis and ulcerative colitis, Other
+∞
17.7
17
*
JAP00
NOMESCO Finland
Freeing of adhesions in the peritoneal cavity
8.1
17.5
39
49
K62.5
ICD-10 Finland
Haemorrhage of anus and rectum
2.8
17.0
109
397
J01DB01
ATC
cefalexin; oral
1.6
16.9
1653
14693
D12.6
ICD-10 Finland
Benign neoplasm: Colon, unspecified
3.1
16.8
96
324
K75.9
ICD-10 Finland
Inflammatory liver disease, unspecified
7.5
16.7
39
53
56300
ICD-8 Finland
Chronic enteritis and ulcerative colitis, Regional enteritis
+∞
16.7
16
*
5552A
ICD-9 Finland
Regional enteritis, Small intestine with large intestine
+∞
16.7
16
*
5761C
ICD-9 Finland
Other disorders of biliary tract, Cholangitis[CHOLANGITIS SCLEROSIVA]
+∞
16.7
16
*
D16
ICPC
Rectal bleeding
4.5
16.6
59
135
JFA58
NOMESCO Finland
Endoscopic dilatation of colon
27.8
16.5
22
8
E86
ICD-10 Finland
Volume depletion
5.0
16.2
52
107
N02AJ06
ATC
codeine and paracetamol; systemic
1.5
16.1
717
5359
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.7
16.1
391
2509
JKE32
NOMESCO Finland
Endoscopic dilatation of bile duct
24.7
16.0
22
9
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.5
15.9
882
6902
K92.2
ICD-10 Finland
Gastrointestinal haemorrhage, unspecified
4.2
15.9
61
150
A03CA02
ATC
clidinium and psycholeptics; oral
2.8
15.7
101
369
JFG50
NOMESCO Finland
Laparotomy with revision of enterostomy or colostomy
+∞
15.6
15
*
K83.8
ICD-10 Finland
Other specified diseases of biliary tract
19.4
15.5
23
12
JF1AD
NOMESCO Finland
Small bowel CT
13.8
15.5
26
19
A02BA02
ATC
ranitidine; systemic
1.7
15.1
316
1939
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
2.1
15.0
177
886
SPAT1255
SPAT
Intravenous administration of medicine
2.4
14.9
128
552
0093A
ICD-9 Finland
Ill-defined intestinal infections, Diarrhoea of presumed infectious origin
5.7
14.8
42
75
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.8
14.8
253
1455
K60.4
ICD-10 Finland
Rectal fistula
31.9
14.8
19
6
E27.3
ICD-10 Finland
Drug-induced adrenocortical insufficiency
16.6
14.8
23
14
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
2.4
14.7
128
554
JFH00
NOMESCO Finland
Total colectomy and ileorectal anastomosis
18.5
14.7
22
12
J02AC01
ATC
fluconazole; systemic
1.5
14.5
731
5576
TJJ00
NOMESCO Finland
Percutaneous needle biopsy of liver
12.6
14.4
25
20
D11
ICPC
Diarrhoea
1.9
14.3
234
1324
XX6XT
NOMESCO Finland
Other intravascular therapy with radiological guidance
14.5
14.0
23
16
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.6
13.9
358
2326
UJH02
NOMESCO Finland
Anoscopy
2.8
13.9
87
314
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
2.0
13.7
194
1041
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.1
13.7
165
832
D64.9
ICD-10 Finland
Anaemia, unspecified
2.1
13.7
154
755
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.0
13.6
181
951
Z43.2
ICD-10 Finland
Attention to ileostomy
34.2
13.5
17
5
5604
FHL
Vascular preparation or cannulation in the operating room
25.9
13.4
18
7
TPH05
NOMESCO Finland
Open cannulation of peripheral vein
7.8
13.4
30
39
SPAT1125
SPAT
Stoma care and guidance
6.2
13.3
35
57
J01DA01
ATC
[U] cefalexin; systemic
1.4
13.3
1197
10151
E0000UV
ATC
NA
1.4
13.2
724
5592
NA6BG
NOMESCO Finland
Sacro-iliac joint MRI examination with high intensity magnet
4.1
13.2
51
128
B80
ICPC
Iron deficiency anaemia
4.0
12.9
50
126
WW200
NOMESCO Finland
Immunization
3.1
12.6
68
223
TJD00
NOMESCO Finland
Insertion of nasogastric or naso-gastroduodenal tube
5.1
12.6
39
78
JFA38
NOMESCO Finland
Endoscopic dilatation of small intestine
+∞
12.5
12
*
56902
ICD-8 Finland
Other diseases of intestines and peritoneum, Proctitis haemorrhagica (ulcerosa)
+∞
12.5
12
*
B03BA03
ATC
hydroxocobalamin; parenteral
2.6
12.5
93
372
JL5CG
NOMESCO Finland
Extensive MRI examinaiton of bile and pancreas ducts with high intesity magnet
7.3
12.5
29
40
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.6
12.5
317
2052
K55.9
ICD-10 Finland
Vascular disorder of intestine, unspecified
20.2
12.5
18
9
B01AB10
ATC
tinzaparin; parenteral
2.3
12.4
119
542
K83.9
ICD-10 Finland
Disease of biliary tract, unspecified
13.2
12.4
21
16
K58.0
ICD-10 Finland
Irritable bowel syndrome with diarrhoea
2.4
12.4
110
482
R4190
NOMESCO Finland
Nutritional therapy
2.9
12.3
76
271
ZXC86
NOMESCO Finland
Use of endoscopic device
8.0
12.3
27
34
K76.9
ICD-10 Finland
Liver disease, unspecified
5.1
12.3
38
76
JKD20
NOMESCO Finland
Anastomosis of bile duct to jejunum
37.8
12.2
15
*
M81.4
ICD-10 Finland
Drug-induced osteoporosis
12.5
12.1
21
17
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
2.6
12.0
86
336
D99
ICPC
Disease digestive system other
5.8
11.9
33
58
H20.0
ICD-10 Finland
Acute and subacute iridocyclitis
2.6
11.9
89
357
D18
ICPC
Change in faeces/bowel movements
3.9
11.9
48
126
OAB74
NOMESCO Finland
Nutritional guidance related to treatment and rehabilitation for medical condition
7.1
11.8
28
40
JFA70
NOMESCO Finland
Suture of small intestine
14.7
11.8
19
13
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
2.8
11.6
76
281
K62.4
ICD-10 Finland
Stenosis of anus and rectum
23.0
11.6
16
7
K74.3
ICD-10 Finland
Primary biliary cirrhosis
8.7
11.5
24
28
JFG96
NOMESCO Finland
Other operation on intestinal stoma or pouch
+∞
11.5
11
*
5551A
ICD-9 Finland
Regional enteritis, Large intestine
+∞
11.5
11
*
K73.2
ICD-10 Finland
Chronic active hepatitis, not elsewhere classified
13.7
11.4
19
14
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.8
11.4
216
1283
A07AA02
ATC
nystatin; oral
2.2
11.3
109
499
JHD33
NOMESCO Finland
Completing incision of fistula-in-ano
15.1
11.3
18
12
WX892
NOMESCO Finland
Monitored bed care
2.1
11.3
130
645
JAD30
NOMESCO Finland
Repair of incisional hernia using prosthetic material
4.0
11.2
43
108
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.4
11.2
756
6027
K73.9
ICD-10 Finland
Chronic hepatitis, unspecified
20.1
11.1
16
8
127
Kela drug reimbursment
Transplant complication
4.2
11.0
41
100
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
2.9
11.0
64
222
WZC30
NOMESCO Finland
Teaching
1.7
10.9
221
1338
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.1
10.8
129
647
WW500
NOMESCO Finland
Blood transfusion
2.7
10.8
74
284
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.8
10.8
201
1185
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
2.2
10.8
111
525
D07AC01
ATC
betamethasone; topical
1.4
10.8
590
4519
R53
ICD-10 Finland
Malaise and fatigue
1.6
10.7
334
2271
6525
FHL
Enterostomy occlusion
28.2
10.7
14
5
N03AX16
ATC
pregabalin; oral
1.5
10.7
385
2707
JFA76
NOMESCO Finland
Closure of fistula of small intestine
60.3
10.6
12
*
Z93.3
ICD-10 Finland
Colostomy status
7.3
10.5
24
33
L02.3
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of buttock
3.3
10.4
51
157
JF1CM
NOMESCO Finland
Small bowel extensive MRI with with high intensity magnet
110.5
10.4
11
*
6408
FHL
Colectomy and ileostomy
+∞
10.4
10
*
M09.1*K50.9
ICD-10 Finland
Juvenile arthritis in Crohn's disease [regional enteritis]
+∞
10.4
10
*
K65.0
ICD-10 Finland
Acute peritonitis
5.6
10.4
29
52
T81.8
ICD-10 Finland
Other complications of procedures, not elsewhere classified
3.6
10.4
45
126
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.7
10.4
201
1202
D07AB02
ATC
hydrocortisone butyrate; topical
1.4
10.3
491
3660
JJ9AE
NOMESCO Finland
Ultrasound examination of liver transplant
18.9
10.3
15
8
JWA00
NOMESCO Finland
Repair of wound dehiscence in gastroenterological surgery
10.1
10.0
19
19
SPAT1153
SPAT
Removal of sutures
1.4
10.0
503
3785
K91.8
ICD-10 Finland
Other postprocedural disorders of digestive system, not elsewhere classified
40.3
10.0
12
*
D06BX01
ATC
metronidazole; topical
1.8
9.9
184
1087
WX704
NOMESCO Finland
Intubation
2.0
9.8
123
632
JKE02
NOMESCO Finland
Transduodenal endoscopic incision of common bile duct orifice
4.8
9.6
31
66
A04.9
ICD-10 Finland
Bacterial intestinal infection, unspecified
7.8
9.6
21
27
E000001
ATC
NA
1.5
9.6
368
2616
UKC02
NOMESCO Finland
Cystoscopy
1.7
9.6
224
1415
7200A
ICD-9 Finland
Ankylosing spondylitis and other inflammatory spondylopathies, Ankylosing spondylitis
10.1
9.5
18
18
JFF11
NOMESCO Finland
Laparoscopic loop enterostomy
15.1
9.5
15
10
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.6
9.5
251
1637
K52.0
ICD-10 Finland
Gastroenteritis and colitis due to radiation
100.5
9.4
10
*
5589X
ICD-9 Finland
Other non-infective gastro-enteritis and colitis, Other and unspecified non-infectious gastro-enteritis and colitis
+∞
9.4
9
*
JFH01
NOMESCO Finland
Laparoscopic colectomy with ileorectal anastomosis
+∞
9.4
9
*
5563A
ICD-9 Finland
Idiopathic proctocolitis, Ulcerative (chronic) proctosigmoiditis
+∞
9.4
9
*
JF1DM
NOMESCO Finland
Very extensive MRI of small bowel (more than 1.5 T)
+∞
9.4
9
*
K61.1
ICD-10 Finland
Rectal abscess
9.5
9.3
18
19
JHD20
NOMESCO Finland
Incision of fistula-in-ano
4.4
9.2
32
74
1300
FHL
Esophagogastroduodenoscopy (also includes staining)
5.7
9.2
25
44
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.6
9.2
274
1843
QBE15
NOMESCO Finland
Excision of other superficial lesion of skin of trunk
7.8
9.1
20
26
K83.1
ICD-10 Finland
Obstruction of bile duct
4.6
9.1
30
66
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
2.3
9.0
80
352
XJW99
NOMESCO Finland
Other investigative procedure on digestive system
9.1
9.0
18
20
Z50.1
ICD-10 Finland
Other physical therapy
2.1
8.9
95
457
C05AA01
ATC
hydrocortisone; rectal, topical
2.2
8.9
85
389
XQ802
NOMESCO Finland
Epicutan test
2.3
8.9
79
349
A02BA04
ATC
nizatidine; systemic
2.0
8.8
118
620
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
1.9
8.8
120
638
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.5
8.8
309
2158
D07AD01
ATC
clobetasol; topical
1.6
8.7
252
1680
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.4
8.7
578
4547
JFB30
NOMESCO Finland
Right hemicolectomy
4.9
8.7
27
56
SPAT1149
SPAT
Suture or treatment of traumatic wound
1.7
8.7
193
1202
SPAT1249
SPAT
Treatment-related counselling outside office
1.3
8.7
693
5625
M25.5
ICD-10 Finland
Pain in joint
1.4
8.6
485
3712
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
2.2
8.6
86
404
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.4
8.6
533
4148
JFK10
NOMESCO Finland
Freeing of adhesions in intestinal obstruction
11.6
8.6
15
13
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
2.0
8.5
108
559
K63.9
ICD-10 Finland
Disease of intestine, unspecified
9.0
8.5
17
19
M07.4
ICD-10 Finland
Arthropathy in Crohn disease [regional enteritis]
90.4
8.4
9
*
N02AA05
ATC
oxycodone; systemic
1.7
8.4
195
1226
L88
ICD-10 Finland
Pyoderma gangrenosum
12.8
8.4
14
11
SPAT1104
SPAT
Monitoring of emergency patient
2.0
8.3
108
562
JFG70
NOMESCO Finland
Conversion of continent ileostomy to conventional ileostomy
+∞
8.3
8
*
4AC05
NOMESCO Finland
NA
+∞
8.3
8
*
K29.3
ICD-10 Finland
Chronic superficial gastritis
2.7
8.3
53
197
D01
ICPC
Abdominal pain/cramps general
1.7
8.3
189
1184
K85.9
ICD-10 Finland
Acute pancreatitis, unspecified
3.3
8.2
39
119
WX720
NOMESCO Finland
Own respiration
2.3
8.2
70
305
SAA02
NOMESCO Finland
Basic examination of mouth
1.3
8.2
1262
11222
J01MA01
ATC
ofloxacin; systemic
1.8
8.2
134
758
L40.0
ICD-10 Finland
Psoriasis vulgaris
2.1
8.2
85
405
SPAT1260
SPAT
Consultation of another employee
1.5
8.2
287
1997
M01AE01
ATC
ibuprofen; systemic, rectal
0.7
8.2
1611
17232
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
1.4
8.2
439
3329
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.5
8.2
288
2009
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
1.4
8.1
373
2745
313
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)
2.5
8.1
60
244
K52.2
ICD-10 Finland
Allergic and dietetic gastroenteritis and colitis
33.5
8.1
10
*
K80.3
ICD-10 Finland
Calculus of bile duct with cholangitis
6.8
8.1
19
28
B01AA03
ATC
warfarin; systemic
1.6
8.0
240
1612
N11.9
ICD-10 Finland
Chronic tubulo-interstitial nephritis, unspecified
10.1
8.0
15
15
A06AC51
ATC
ispaghula, combinations; systemic
2.1
7.9
83
396
S18
ICPC
Laceration/cut
1.3
7.9
660
5370
K85
ICD-10 Finland
Acute pancreatitis
3.3
7.9
37
112
R74.0
ICD-10 Finland
Elevation of levels of transaminase and lactic acid dehydrogenase [LDH]
3.2
7.9
39
123
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
1.9
7.9
117
644
R06.0
ICD-10 Finland
Dyspnoea
1.4
7.9
361
2654
B07.9
ICD-10 Finland
Verruca simplex
2.4
7.9
64
271
N05CF01
ATC
zopiclone; oral
1.4
7.8
484
3761
R11
ICD-10 Finland
Nausea and vomiting
1.8
7.8
125
704
SPAT1254
SPAT
Administration of medicine
1.6
7.8
215
1419
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
2.3
7.8
70
315
JWF00
NOMESCO Finland
Reoperation for insufficiency of anastomosis or suture in gastroenterological surgery
15.1
7.7
12
8
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
2.5
7.7
55
220
E000003
ATC
NA
2.1
7.7
86
424
JKA20
NOMESCO Finland
Cholecystectomy
2.8
7.7
46
166
J01FA10
ATC
azithromycin; systemic
1.3
7.6
1113
9780
L04AA06
ATC
mycophenolic acid; systemic
3.1
7.6
39
127
JWW96
NOMESCO Finland
Other reoperation in gastroenterological surgery
18.4
7.6
11
6
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
1.6
7.6
182
1157
JX1LA
NOMESCO Finland
Kinetic X-ray of alimentary tract with pictures
25.1
7.6
10
*
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
1.9
7.6
104
555
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.6
7.5
215
1427
D12.3
ICD-10 Finland
Benign neoplasm: Transverse colon
3.1
7.5
39
128
C10AC02
ATC
colestipol; oral
10.1
7.5
14
14
281
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab
2.5
7.5
56
228
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
2.0
7.5
87
435
J45.9
ICD-10 Finland
Asthma, unspecified
1.5
7.5
275
1934
A01AB09
ATC
miconazole; local oral
1.7
7.5
137
806
K76.0
ICD-10 Finland
Fatty (change of) liver, not elsewhere classified
2.7
7.4
48
180
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
1.7
7.4
152
926
JN3DE
NOMESCO Finland
Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation
7.7
7.4
16
21
JG1JB
NOMESCO Finland
Defekography with X-ray
6.0
7.4
19
32
ZX100
NOMESCO Finland
Oral
3.9
7.4
28
72
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.4
7.3
482
3775
I84.2
ICD-10 Finland
Internal hemorrhoids without complication
1.8
7.3
114
638
N18.8
ICD-10 Finland
Other chronic renal failure
2.8
7.3
43
153
D07AC13
ATC
mometasone; topical
1.4
7.3
485
3804
6437
FHL
Rectum resection and sphincter-sparing through-anastomosis
+∞
7.3
7
*
JGB61
NOMESCO Finland
Laparoscopic excision of rectum and ileoanal anastomosis
+∞
7.3
7
*
WX110
NOMESCO Finland
Local anesthesy
1.3
7.3
1327
11971
R10.0
ICD-10 Finland
Acute abdomen
2.4
7.3
60
256
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
1.8
7.2
122
700
JAD10
NOMESCO Finland
Repair of incisional hernia
5.8
7.2
19
33
D07CA01
ATC
hydrocortisone and antibiotics; topical
1.5
7.2
220
1488
UGC12
NOMESCO Finland
Flexible bronchoscopy
1.8
7.2
114
640
JGB96
NOMESCO Finland
Other proctectomy or excision of rectum
30.1
7.1
9
*
K86.1
ICD-10 Finland
Other chronic pancreatitis
4.8
7.1
22
46
JJ5AT
NOMESCO Finland
NA
20.1
7.1
10
5
A10AE05
ATC
insulin detemir; parenteral
1.9
7.0
96
516
SPAT1325
SPAT
Vaccination
1.3
7.0
505
4009
M46.1
ICD-10 Finland
Sacroiliitis, not elsewhere classified
3.3
6.9
32
97
J05AB01
ATC
aciclovir; systemic
1.4
6.9
343
2554
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
2.5
6.9
52
214
SFA10
NOMESCO Finland
Fillning on one surface of tooth
1.3
6.8
1001
8750
71240
ICD-8 Finland
Rheumatoid arthritis and allied conditions, Spondylitis ankylopoietica
9.3
6.8
13
14
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.4
6.8
279
2008
B02.9
ICD-10 Finland
Zoster without complication
2.0
6.7
79
398
J01MA14
ATC
moxifloxacin; systemic
1.7
6.7
140
858
JAH01
NOMESCO Finland
Laparoscopy
2.0
6.7
81
414
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
4.1
6.7
24
59
SPAT1312
SPAT
General health counselling
1.3
6.7
554
4488
K45.8
ICD-10 Finland
Other specified abdominal hernia without obstruction or gangrene
6.4
6.6
16
25
M13.9
ICD-10 Finland
Arthritis, unspecified
1.8
6.6
115
670
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.5
6.6
258
1840
J01FF01
ATC
clindamycin; systemic
1.3
6.6
441
3460
ZX121
NOMESCO Finland
Central venous catheter
8.7
6.5
13
15
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
2.0
6.5
82
427
K90.0
ICD-10 Finland
Coeliac disease
2.4
6.5
53
228
JJ1LE
NOMESCO Finland
Ultrasound elastography of liver
4.1
6.5
23
56
L88
ICPC
Rheumatoid/seropositive arthritis
2.3
6.5
58
260
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.5
6.5
222
1537
J01FA06
ATC
roxithromycin; oral
1.3
6.5
687
5752
A12BA01
ATC
potassium chloride; oral
2.4
6.5
50
210
JN3CG
NOMESCO Finland
Extensive MRI examination of abdomen with high intensity magnet
6.2
6.5
16
26
F32.11
ICD-10 Finland
Moderate depressive episode with somatic syndrome
2.3
6.5
55
241
R01AD08
ATC
fluticasone; nasal
1.3
6.5
498
3989
ND2DA
NOMESCO Finland
Bilateral hand X-ray examination
2.8
6.4
39
143
D12.5
ICD-10 Finland
Benign neoplasm: Sigmoid colon
2.2
6.4
58
262
N82.4
ICD-10 Finland
Other female intestinal-genital tract fistulae
70.1
6.4
7
*
JHB30
NOMESCO Finland
Rubber band ligature of haemorrhoids or prolapse of mucosa
1.9
6.4
83
435
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.6
6.4
161
1039
M02AA07
ATC
piroxicam; topical
1.3
6.4
531
4297
ZJX00
NOMESCO Finland
Double balloon technique in gastroenterological endoscopy
14.3
6.4
10
7
N82.3
ICD-10 Finland
Fistula of vagina to large intestine
14.3
6.4
10
7
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.4
6.3
295
2173
Z35.8
ICD-10 Finland
Supervision of other high-risk pregnancies
1.6
6.3
143
897
WX004
NOMESCO Finland
Patient-controlled sedation
6.0
6.3
16
27
JN1CM
NOMESCO Finland
Upper part of abdomen extensive MRI examination with 3 Tesla magnet
11.0
6.3
11
10
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
1.6
6.3
155
995
A07AA11
ATC
rifaximin; oral
9.3
6.3
12
13
C03CA01
ATC
furosemide; systemic
1.4
6.3
317
2370
K80.2
ICD-10 Finland
Calculus of gallbladder without cholecystitis
1.6
6.2
167
1095
TGC00
NOMESCO Finland
Bronchial lavation
2.5
6.2
44
175
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
1.7
6.1
119
714
JH1CM
NOMESCO Finland
Perianal extensive MRI with 3 Tesla magnet
12.5
6.1
10
8
K91.2
ICD-10 Finland
Postsurgical malabsorption, not elsewhere classified
12.5
6.1
10
8
N70.1
ICD-10 Finland
Chronic salpingitis and oophoritis
3.9
6.1
23
60
JHA20
NOMESCO Finland
Excision of lesion of anal canal or perianal tissue
3.9
6.1
23
60
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.6
6.1
165
1085
N17.9
ICD-10 Finland
Acute renal failure, unspecified
2.3
6.1
50
217
K29.5
ICD-10 Finland
Chronic gastritis, unspecified
2.6
6.1
40
154
JJA20
NOMESCO Finland
Open biopsy of liver
8.6
6.1
12
14
H25.8
ICD-10 Finland
Other senile cataract
1.8
6.0
105
612
Y83.9
ICD-10 Finland
Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.4
6.0
47
199
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3006315) Basophils [#/volume] in Blood
1879
9153
6.33
321.03
14.9
5.6
e9/l
0.0
0.0
2.57
1777
7970
(3001604) Monocytes [#/volume] in Blood
1875
9125
6.29
320.47
14.8
5.6
e9/l
0.6
0.6
0.70
1772
7949
(3013115) Eosinophils [#/volume] in Blood
1903
9494
6.36
312.04
15.1
5.9
e9/l
0.2
0.2
0.00
1795
8411
(3017181) Myelocytes/100 leukocytes in Blood
659
1406
6.13
308.24
6.9
4.1
%
0.7
0.8
0.32
179
389
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
281
17
187.69
307.65
3.6
2.5
mg/l
8.0
6.0
0.93
238
12
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
512
510
12.57
307.65
1.7
1.5
iu/ml
10.8
0.1
0.59
117
89
(42870588) Differential panel, method unspecified - Blood
1502
5942
5.26
307.65
12.1
5.7
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
1699
7128
6.04
307.65
4.2
2.1
nmol/l
73.8
74.8
0.82
1644
6498
(3048689) Calprotectin [Mass/mass] in Stool
1789
1954
35.54
307.65
7.7
1.3
ug/g
244.0
87.6
38.98
1707
1487
(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay
256
18
159.55
307.65
3.0
2.5
au/ml
71.3
252.0
—
37
5
(3022145) Colonoscopy Study observation
1343
1617
18.13
307.65
2.4
1.2
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
1863
6963
9.19
307.65
11.7
4.5
g/l
36.3
36.2
0.75
1819
6490
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
803
963
12.17
307.65
2.4
1.5
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
626
1279
6.32
306.39
6.3
3.9
%
0.4
0.7
2.21
136
285
(3019198) Lymphocytes [#/volume] in Blood
1889
9453
6.16
305.93
14.9
5.6
e9/l
1.8
2.0
2.92
1801
8409
(3022096) Basophils/100 leukocytes in Blood
1755
8293
5.45
304.91
14.8
5.8
%
0.7
0.7
7.92
1691
7767
(3006504) Eosinophils/100 leukocytes in Blood
1778
8559
5.47
299.62
14.8
5.7
%
2.8
2.8
0.12
1711
7997
(3019069) Monocytes/100 leukocytes in Blood
1784
8616
5.49
299.23
15.2
6.0
%
8.8
8.5
4.80
1720
8101
(3025159) Blasts/100 leukocytes in Blood
614
1264
6.23
297.52
7.1
4.2
%
0.0
0.6
0.92
142
305
(3018010) Neutrophils/100 leukocytes in Blood
1790
8802
5.39
289.49
14.1
5.6
%
57.4
56.7
1.92
1728
8274
(3021440) Promyelocytes/100 leukocytes in Blood
622
1339
5.96
286.56
7.2
4.2
%
0.1
0.1
1.21
167
358
(3002030) Lymphocytes/100 leukocytes in Blood
1799
8928
5.38
286.15
15.0
5.7
%
28.3
28.6
0.92
1736
8367
(3013650) Neutrophils [#/volume] in Blood by Automated count
1932
10566
5.73
259.91
17.2
8.8
e9/l
4.0
4.1
1.60
1838
9264
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
2207
13759
11.48
248.36
19.9
6.8
u/l
77.7
76.1
0.94
2161
12967
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
1090
4086
4.12
245.00
4.2
2.0
mg/l
3.1
2.9
3.13
1009
3487
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
298
361
9.31
232.59
4.0
6.8
iu/ml
792.9
400.5
0.68
44
50
(44786774) Adalimumab [Mass/volume] in Serum or Plasma
135
33
43.35
225.39
2.5
1.3
mg/l
9.5
8.8
0.27
112
26
(40760892) CBC W Ordered Manual Differential panel - Blood
1060
4338
3.64
200.79
11.6
4.1
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
293
491
6.68
170.71
2.1
1.2
titre
81.3
100.4
0.55
32
45
(3013707) Erythrocyte sedimentation rate by Westergren method
2024
13511
4.67
160.70
8.5
3.7
mm/h
12.7
10.4
11.62
1914
12602
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
642
2149
3.74
160.29
3.1
2.5
%
20.6
24.3
8.18
549
1850
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
161
148
11.61
152.41
2.3
1.2
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
408
1020
4.63
151.72
1.6
1.2
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
222
323
7.49
147.14
5.7
3.4
%
57.9
56.4
0.82
222
323
(3030905) Polymorphonuclear cells [#/volume] in Blood
218
311
7.63
147.05
5.6
3.1
e9/l
4.0
4.1
0.47
218
311
(3022948) Iron [Moles/volume] in Serum or Plasma
688
2543
3.41
145.69
3.1
2.4
umol/l
12.2
14.0
8.51
671
2355
(3004789) Transferrin [Mass/volume] in Serum or Plasma
652
2331
3.49
145.60
3.1
2.4
g/l
2.4
2.4
3.28
632
2165
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1213
6270
2.94
141.68
6.0
3.2
u/l
30.9
34.6
0.74
1140
5986
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
1099
5470
2.90
136.42
4.8
2.5
u/l
62.4
56.4
1.91
1054
5068
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
1524
9050
2.96
134.72
9.8
6.0
umol/l
10.3
11.4
4.15
1476
8591
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
208
320
7.04
130.73
1.6
1.4
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
1415
8191
2.84
129.25
18.6
8.7
e9/l
0.0
0.0
1.01
1310
6703
(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay
118
0
+∞
124.07
3.1
0.0
mg/l
22.4
—
—
113
0
(3028026) IgM [Mass/volume] in Serum or Plasma
384
1062
4.13
123.77
2.2
1.8
g/l
1.3
1.4
0.55
362
978
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
116
0
+∞
121.95
3.1
0.0
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
658
2602
3.13
121.81
1.6
1.6
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
440
1378
3.70
118.40
3.0
2.6
g/l
11.8
10.5
6.93
415
1262
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
213
375
6.15
117.14
1.5
1.2
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
457
1530
3.47
110.49
4.1
2.2
g/l
0.2
0.2
1.89
432
1424
(3024980) IgG subclass 4 [Mass/volume] in Serum
179
286
6.69
108.23
2.5
1.6
g/l
0.9
0.9
0.02
150
215
(3001122) Ferritin [Mass/volume] in Serum or Plasma
1385
8385
2.60
108.16
4.5
2.7
ug/l
108.8
116.5
0.36
1325
7855
(3032080) INR in Blood by Coagulation assay
1156
6534
2.52
102.89
10.6
7.8
inr
1.1
1.2
2.20
428
2015
(3037522) Nuclear Ab [Titer] in Serum
610
2604
2.82
95.47
1.8
1.3
titre
528.0
488.3
0.22
184
504
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
112
119
9.83
95.42
2.6
1.3
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
230
524
4.76
94.41
5.7
3.4
u/ml
65.9
2796.9
0.81
210
447
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
116
135
8.99
92.21
1.6
1.1
titre
360.4
150.5
1.59
49
20
(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum
116
135
8.99
92.21
1.6
1.1
titre
245.0
314.0
—
6
5
(3023368) Bacteria identified in Blood by Culture
835
4314
2.45
87.02
5.3
4.2
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
744
3647
2.52
86.91
1.6
1.6
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
235
591
4.31
84.90
2.2
1.5
titre
386.1
281.4
0.20
23
14
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
196
436
4.81
82.60
2.0
1.2
iu/ml
4.4
6.9
—
6
7
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
1283
8233
2.23
77.66
8.7
6.6
mmol/l
1.2
1.2
0.34
1092
6995
(3009445) Proteinase 3 Ab [Units/volume] in Serum
255
728
3.81
77.15
1.9
1.5
u/ml
4.8
27.5
1.29
35
17
(40768441) Liver Pathology biopsy report
98
123
8.27
73.22
1.8
1.5
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
182
424
4.57
72.31
1.3
1.3
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
2263
19253
6.20
70.96
31.3
11.8
mg/l
16.3
22.7
29.89
2072
14906
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
174
405
4.56
69.16
1.4
1.3
u/ml
278.4
256.3
0.34
92
254
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
131
241
5.70
68.33
4.1
2.8
u/ml
6.1
75.1
0.68
131
220
(3019309) Folate [Moles/volume] in Red Blood Cells
560
2680
2.43
66.46
2.1
1.7
nmol/l
1170.0
1179.4
0.07
428
2084
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
652
3404
2.27
62.80
2.3
1.6
pmol/l
18664818.0
43763417.8
0.59
584
2886
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
39
11
36.04
62.03
1.0
1.0
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
207
600
3.69
60.90
1.9
1.8
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
1461
10431
2.07
60.39
6.3
4.7
mmol/l
6.6
6.6
0.01
1375
9681
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
106
180
6.12
60.03
1.8
1.5
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
1039
6600
2.03
59.19
2.1
1.8
pmol/l
97.0
96.6
0.09
662
3555
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
106
184
5.99
58.70
1.8
1.5
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
120
239
5.24
57.31
1.4
1.3
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
1659
12532
2.11
57.25
5.5
3.9
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
120
240
5.22
57.04
3.2
3.5
%
1.4
1.7
0.31
96
205
(3025468) Yersinia sp identified in Specimen by Organism specific culture
103
179
5.97
56.96
1.8
1.5
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
104
184
5.87
56.46
1.8
1.5
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
103
181
5.91
56.31
1.8
1.5
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
103
181
5.91
56.31
1.8
1.5
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
355
1477
2.65
55.85
5.9
4.2
ug/l
6.3
24.0
1.80
285
1195
(1761482) Bacteria [#/volume] in Urine by Culture
148
359
4.33
55.66
4.7
4.1
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
221
713
3.32
54.96
1.4
1.3
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
1094
7264
1.95
53.10
2.8
2.0
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
831
5066
1.99
51.37
4.5
2.9
—
—
—
0
0
(3010375) cycloSPORINE [Mass/volume] in Blood
65
81
8.23
48.77
25.1
27.0
ug/l
128.0
125.1
0.09
60
64
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
87
150
5.99
48.48
1.7
1.5
umol/l
11.2
11.7
0.31
87
140
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
1045
6998
1.89
47.89
4.7
3.3
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
1095
7458
1.88
47.46
7.3
5.9
mmol/l
1.2
1.2
0.00
1022
6796
(3042936) Bacteria identified in Isolate by Culture
483
2481
2.19
46.73
2.4
2.1
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
666
3861
2.01
46.67
2.0
1.4
g/l
2.5
2.3
1.95
513
2456
(3026782) Osmolality of Urine
595
3328
2.06
45.96
3.3
2.6
mosm/kgh2o
558.5
554.5
0.14
542
2831
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
122
300
4.24
45.00
5.7
3.8
u/ml
23.5
1292.2
0.87
112
281
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
84
153
5.66
44.20
1.3
1.2
u/l
77.0
57.4
0.61
56
106
(3014576) Chloride [Moles/volume] in Serum or Plasma
413
2036
2.25
43.99
9.8
7.4
mmol/l
104.8
104.4
1.31
408
1991
(3036481) Cortisol [Moles/volume] in Serum or Plasma
372
1760
2.32
43.66
2.6
2.2
nmol/l
325.8
374.0
5.00
352
1633
(3027273) Bicarbonate [Moles/volume] in Venous blood
200
701
3.03
43.03
5.7
3.4
mmol/l
25.0
25.2
0.34
194
678
(3002032) Base excess in Venous blood by calculation
323
1452
2.42
42.52
6.0
3.8
mmol/l
1.8
2.0
0.32
261
1159
(46235355) HIV 1 and 2 tests - Meaningful Use set
740
4572
1.90
42.26
1.8
1.9
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
1237
8959
1.81
42.12
4.4
3.3
estimate
0.0
0.0
0.80
330
1637
(3021447) Carbon dioxide [Partial pressure] in Venous blood
323
1459
2.41
42.04
6.0
3.8
kpa
5.8
5.9
0.40
315
1414
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
108
256
4.37
41.77
1.2
1.1
g/l
1.5
1.5
0.56
99
228
(3009261) Glucose [Presence] in Urine by Test strip
1244
9067
1.79
41.05
4.6
3.3
estimate
0.0
0.0
0.80
338
1603
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
398
1986
2.21
40.92
5.5
2.7
umol/l
6.5
7.9
1.30
362
1727
(3033705) Calcium.ionized [Moles/volume] in Venous blood
82
158
5.34
40.59
2.9
2.7
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
1231
8980
1.78
40.16
6.3
4.5
estimate
0.0
0.0
0.50
345
1682
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
2079
17973
2.40
39.85
23.7
10.7
ml/min/173m2
87.9
87.3
0.62
1879
14758
(3020564) Creatinine [Moles/volume] in Serum or Plasma
2263
20465
4.14
39.05
31.7
13.4
umol/l
78.9
75.6
3.82
2263
20458
(3007930) Methemoglobin/Hemoglobin.total in Blood
180
629
3.02
38.86
4.8
5.1
%
1.0
0.9
1.80
175
587
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
178
632
2.97
37.34
4.8
5.1
%
1.6
1.7
0.61
173
590
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
2266
20583
4.11
37.28
25.2
9.0
u/l
27.8
27.8
0.02
2245
19948
(40761536) Microorganisms panel - Urine sediment
321
1529
2.27
36.71
4.4
3.5
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
105
270
4.02
36.45
1.2
1.2
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
342
1679
2.21
36.32
3.6
2.4
u/l
45.1
67.6
0.36
318
1434
(3002385) Erythrocyte distribution width [Ratio]
1928
16392
2.00
35.29
32.5
14.5
%
13.8
13.5
13.91
1920
16048
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
1170
8620
1.71
35.01
5.6
3.9
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
108
294
3.80
34.62
1.1
1.1
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
431
2368
2.01
33.83
1.3
1.2
—
—
—
0
0
(3013512) EKG study
715
4634
1.78
33.48
4.1
3.4
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
206
837
2.60
33.35
3.3
2.7
e6/l
0.4
0.2
0.96
201
811
(3024354) Oxygen [Partial pressure] in Venous blood
263
1200
2.34
33.12
5.2
3.1
kpa
4.5
4.7
1.04
256
1158
(3000330) Specific gravity of Urine by Test strip
192
760
2.66
32.75
4.9
3.2
—
—
—
0
0
(40758558) Short blood count panel - Blood
705
4597
1.76
32.07
11.5
6.6
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
2149
19228
2.43
31.56
24.1
13.3
mmol/l
139.3
139.7
12.30
2112
18735
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
45
61
7.50
31.43
1.9
2.4
u/ml
9705.3
34353.1
—
6
14
(3015736) pH of Urine
967
6906
1.68
31.40
3.8
3.1
—
5.8
—
0
7
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
62
118
5.37
31.12
1.2
1.2
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
62
118
5.37
31.12
1.2
1.2
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
219
946
2.45
31.12
5.2
3.1
g/l
129.6
131.3
0.50
209
922
(3021960) Folate [Moles/volume] in Serum or Plasma
580
3613
1.80
30.60
1.6
1.5
nmol/l
19.8
20.4
0.43
521
3143
(3023103) Potassium [Moles/volume] in Serum or Plasma
2151
19304
2.40
30.48
24.2
13.4
mmol/l
3.9
4.0
7.13
2111
18774
(3014765) Yersinia sp identified in Stool by Organism specific culture
144
511
2.94
30.18
1.5
1.1
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
823
5680
1.69
30.08
3.3
2.3
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
701
4636
1.73
29.95
3.3
2.7
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
143
508
2.93
29.91
1.5
1.1
—
—
—
0
0
(3018418) pH of Serum or Plasma
724
4834
1.72
29.87
4.5
3.9
ph
7.4
7.4
0.23
170
942
(42529406) Shigella sp [Presence] in Stool by Culture
144
516
2.91
29.65
1.5
1.1
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
127
424
3.11
29.61
1.4
1.5
—
—
—
0
0
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
51
86
6.04
29.06
1.4
1.1
u/l
100.5
75.5
0.97
43
72
(3006922) Hepatitis E virus Ab [Presence] in Serum
62
127
4.99
28.66
1.1
1.1
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
46
73
6.41
27.83
1.5
1.4
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
759
5224
1.67
27.48
3.8
3.0
e6/l
87.2
86.5
0.00
653
3971
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
46
74
6.32
27.46
1.5
1.4
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
118
395
3.09
27.39
1.4
1.5
u/ml
122.6
120.2
0.04
25
80
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
52
95
5.58
27.29
1.7
1.5
u/l
6.6
7.7
0.14
30
45
(3017732) Neutrophils [#/volume] in Blood
258
1272
2.16
26.74
3.6
2.8
e9/l
4.3
4.1
0.64
194
1048
(3027945) Reticulocytes/100 erythrocytes in Blood
314
1669
2.02
26.62
3.7
2.8
%
1.9
1.8
0.82
285
1501
(3029937) Albumin [Presence] in Urine by Test strip
697
4733
1.67
26.37
4.7
3.6
estimate
0.0
0.0
1.28
333
1621
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
57
117
4.97
26.30
1.1
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
57
118
4.93
26.04
1.1
1.0
—
—
—
0
0
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
48
85
5.74
26.03
1.4
1.1
u/l
42.5
16.4
0.84
40
70
(4062490)
74
189
4.01
25.95
1.3
1.3
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
98
304
3.32
25.80
2.9
3.0
u/ml
160.0
1244.9
0.66
11
17
(3027135) IgG subclass 1 [Mass/volume] in Serum
73
186
4.02
25.69
1.3
1.3
g/l
8.1
6.7
1.28
47
129
(3028192) IgG subclass 2 [Mass/volume] in Serum
73
186
4.02
25.69
1.3
1.3
g/l
3.2
3.0
0.34
47
130
(3024139) IgG subclass 3 [Mass/volume] in Serum
73
186
4.02
25.69
1.3
1.3
g/l
0.4
0.4
0.27
47
128
(3012095) Magnesium [Moles/volume] in Serum or Plasma
453
2752
1.80
25.44
5.6
3.6
mmol/l
0.8
0.8
1.36
421
2597
(3020779) Urea [Moles/volume] in Serum or Plasma
282
1479
2.03
24.73
11.4
8.0
mmol/l
9.3
8.8
0.53
272
1423
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
41
66
6.30
24.47
4.1
2.9
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
258
1316
2.08
24.39
5.2
3.5
mmol/l
1.2
1.2
0.01
239
1138
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
39
60
6.59
24.30
1.6
1.5
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
39
60
6.59
24.30
1.6
1.5
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
376
2189
1.85
24.16
9.0
6.1
mmol/l
1.0
1.0
0.11
361
2046
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
150
610
2.56
24.15
2.3
2.1
ug/l
10.2
1.7
0.44
137
548
(3033658) Prothrombin time (PT) actual/Normal
661
4520
1.64
23.91
7.4
3.8
%
95.8
92.5
2.98
645
4412
(3017354) Segmented neutrophils/100 leukocytes in Blood
62
149
4.25
23.59
3.1
3.4
%
58.8
53.1
1.00
39
107
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
321
1803
1.90
22.99
3.2
4.4
u/l
228.0
245.2
1.25
306
1720
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
162
706
2.39
22.47
1.3
1.4
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
309
1727
1.91
22.44
1.3
1.5
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
680
4750
1.61
22.28
3.7
2.9
e6/l
0.5
0.4
0.24
573
3530
(3007853) Bacteria identified in Skin by Aerobe culture
363
2140
1.82
22.27
1.9
1.7
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
841
6198
1.56
21.76
4.3
3.5
e6/l
103.6
74.1
0.24
687
4285
(4035726)
269
1452
1.96
21.63
1.5
1.4
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
46
93
5.03
21.62
1.1
1.1
miu/ml
1419.5
1587.7
0.48
46
93
(3031040) Bacteria [#/volume] in Urine by Automated count
1425
11789
1.53
21.43
4.9
3.9
e6/l
384.8
1709.5
1.13
18
152
(3023520) Reticulocytes [#/volume] in Blood
235
1214
2.04
21.38
2.9
2.9
e9/l
77.5
71.4
1.22
193
909
(3000850) Epithelial cells [#/volume] in Urine
535
3555
1.65
21.30
3.0
2.5
e6/l
6.2
6.2
0.01
492
3119
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
854
6343
1.55
21.19
3.7
3.2
ng/l
46.5
46.6
0.00
547
3893
(3000570) Elastase.pancreatic [Mass/mass] in Stool
116
445
2.69
21.00
1.5
1.4
ug/g
288.4
298.6
0.20
70
241
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
153
677
2.35
20.50
1.6
2.0
g/l
1.5
1.5
0.21
137
598
(3022217) INR in Platelet poor plasma by Coagulation assay
319
1861
1.83
20.14
20.6
20.2
inr
1.3
1.2
0.02
69
282
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
32
49
6.61
20.03
1.2
1.2
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
37
66
5.68
19.93
1.9
1.6
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
127
523
2.51
19.92
5.1
3.9
mg/l
1.4
1.4
0.07
116
487
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
411
2590
1.71
19.86
2.2
1.8
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
2194
20394
2.20
19.59
24.9
11.1
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
156
714
2.27
19.31
4.0
2.7
%
0.7
0.7
0.72
151
693
(3016650) Hepatitis A virus Ab [Presence] in Serum
95
344
2.84
19.21
1.1
1.1
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
26
33
7.96
19.16
3.3
2.9
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
21
20
10.59
19.12
2.2
1.5
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
34
59
5.83
18.85
1.1
1.3
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
23
26
8.92
18.55
1.9
1.2
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
205
1061
2.02
18.50
1.7
1.4
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
293
1740
1.78
17.31
3.9
3.1
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
193
1001
2.01
17.31
6.9
7.2
mmol/l
23.8
24.4
1.61
177
934
(3016502) Oxygen saturation in Arterial blood
278
1631
1.80
17.10
9.0
8.6
%
96.0
95.9
0.15
261
1577
(3047181) Lactate [Moles/volume] in Blood
120
519
2.38
16.94
6.1
5.8
mmol/l
1.3
1.3
0.24
111
453
(3008898) HLA-B27 [Presence]
165
815
2.10
16.88
1.1
1.1
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
615
4434
1.52
16.68
1.3
1.3
u/ml
0.9
1.6
2.45
167
1246
(3003396) Base excess in Arterial blood by calculation
303
1837
1.75
16.64
8.5
8.1
mmol/l
0.9
1.0
0.15
215
1434
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
303
1837
1.75
16.64
8.5
8.1
kpa
4.9
5.1
3.44
283
1759
(3027801) Oxygen [Partial pressure] in Arterial blood
303
1838
1.74
16.60
8.4
8.1
kpa
12.3
12.6
0.47
284
1763
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
56
162
3.52
16.51
1.1
1.0
mg/l
291.0
287.1
0.13
48
144
(3019060) Gas panel - Arterial blood
195
1034
1.97
16.41
4.9
5.0
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
101
410
2.53
16.35
7.1
2.9
mmol/l
24.1
24.8
0.89
87
366
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
29
50
5.86
16.19
1.2
1.2
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
114
493
2.38
16.10
4.0
3.1
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
196
1053
1.94
15.87
5.8
3.6
kpa
5.1
5.2
0.92
185
988
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
410
2724
1.61
15.84
3.3
2.8
e6/l
3.0
2.5
0.58
274
1444
(3019225) pH of Specimen
265
1578
1.77
15.45
4.9
4.0
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
595
4332
1.50
15.18
3.2
2.2
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
2286
21875
2.88
14.88
41.4
17.5
e9/l
273.3
253.1
33.85
2266
21371
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
99
420
2.42
14.61
1.8
1.7
—
—
—
0
0
(1616796) Gas panel - Central venous blood
89
360
2.53
14.54
4.2
3.7
—
—
—
0
0
(3024731) MCV [Entitic volume]
2286
21895
2.84
14.47
41.1
17.4
fl
91.2
90.4
13.93
2274
21630
(3035941) MCH [Entitic mass]
2286
21898
2.84
14.41
41.0
17.4
pg
30.3
30.2
1.92
2274
21630
(3009343) pH of Capillary blood
190
1043
1.89
14.41
5.9
3.6
ph
7.4
7.4
0.08
31
129
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
85
338
2.57
14.39
1.1
1.1
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
2286
21901
2.83
14.35
41.2
17.4
e12/l
4.5
4.6
23.09
2260
21352
(3011412) CD3 cells [#/volume] in Blood
55
173
3.23
14.26
1.7
2.5
e9/l
1.2
1.2
0.02
28
99
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
575
4205
1.49
14.22
1.8
1.8
mg/l
1.2
1.0
0.77
445
3117
(3002173) Hemoglobin [Mass/volume] in Arterial blood
254
1530
1.74
14.19
9.6
8.8
g/l
120.7
124.1
1.77
243
1478
(3000963) Hemoglobin [Mass/volume] in Blood
2286
21909
2.82
14.19
41.5
17.5
g/l
134.5
137.7
22.60
2276
21638
(36304419) Bacteria [Presence] in Urine
631
4705
1.47
14.13
3.4
2.9
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
16
16
10.06
14.03
1.7
1.1
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
2285
21908
2.77
13.92
41.4
17.5
e9/l
6.9
6.7
2.71
2258
21360
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
183
1006
1.89
13.82
5.9
3.6
mmol/l
1.3
1.6
0.55
135
744
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
164
871
1.95
13.73
12.2
11.0
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
418
2884
1.55
13.55
3.1
2.6
e6/l
1.2
1.1
0.22
281
1601
(3000991) Gas panel - Venous blood
232
1381
1.75
13.50
11.4
9.2
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
52
165
3.20
13.31
3.9
4.0
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
18
24
7.55
12.70
2.2
1.7
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
93
414
2.30
12.35
1.9
1.7
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
42
123
3.46
12.22
1.6
2.0
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
25
49
5.15
12.21
1.1
1.3
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
327
2184
1.58
12.15
1.6
1.4
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
1551
13731
1.38
11.94
5.7
3.0
u/l
61.3
45.2
9.47
1486
13004
(3026389) Candida sp identified in Specimen by Organism specific culture
60
222
2.75
11.76
1.4
1.3
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
103
489
2.16
11.72
3.3
3.3
u/ml
0.3
0.4
1.08
60
267
(3015377) Calcium [Moles/volume] in Serum or Plasma
711
5604
1.39
11.20
4.3
3.3
mmol/l
2.3
2.4
5.47
633
4996
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
114
576
2.03
11.03
1.5
1.6
g/l
1.2
1.2
0.17
102
545
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
30
76
3.99
10.76
3.8
3.2
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
110
554
2.03
10.74
1.5
1.6
g/l
0.2
0.2
1.68
98
525
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
66
274
2.45
10.30
1.5
1.4
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
94
457
2.10
10.10
1.2
1.3
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
59
238
2.52
9.79
1.6
1.4
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
269
1802
1.56
9.79
2.0
1.7
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
21
43
4.92
9.79
1.1
2.0
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
266
1778
1.56
9.78
1.9
1.7
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
81
378
2.18
9.67
4.3
3.2
umol/l
30.1
36.4
1.53
71
333
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
141
800
1.81
9.66
5.9
4.0
mmol/l
24.0
24.1
0.24
132
732
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
111
583
1.95
9.66
2.0
1.8
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
66
284
2.36
9.54
2.6
2.3
umol/l
21.2
5.9
1.67
54
204
(40767503) Oxygen content in Capillary blood by calculation
76
350
2.21
9.38
3.5
2.5
%
16.4
16.6
0.24
43
171
(3018677) aPTT in Platelet poor plasma by Coagulation assay
364
2622
1.46
9.34
2.2
2.3
s
29.2
29.7
1.05
350
2544
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
99
506
2.00
9.32
2.8
2.9
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
39
131
3.01
9.16
1.5
2.1
%
14.3
13.7
0.07
15
71
(3027315) Oxygen [Partial pressure] in Blood
80
381
2.14
9.10
4.4
4.2
kpa
9.0
8.9
0.28
80
375
(3012501) Base excess in Blood by calculation
80
381
2.14
9.10
4.4
4.2
mmol/l
2.2
2.4
0.33
54
248
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
67
297
2.29
9.07
2.1
1.8
—
—
—
0
0
(3013290) Carbon dioxide [Partial pressure] in Blood
80
382
2.13
9.04
4.4
4.2
kpa
5.0
5.0
0.36
80
377
(3014111) Lactate [Moles/volume] in Serum or Plasma
224
1471
1.58
8.89
9.2
7.7
mmol/l
1.3
1.4
0.50
212
1410
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
186
1170
1.64
8.81
4.8
4.1
ng/l
88.2
84.8
0.14
164
1056
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
638
5102
1.34
8.77
2.3
2.1
u/l
295.1
242.1
0.18
607
4829
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
66
296
2.27
8.71
1.7
1.3
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
79
382
2.11
8.66
7.8
3.2
kpa
8.8
8.4
1.08
72
356
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
163
996
1.68
8.64
1.6
1.5
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
41
147
2.82
8.60
1.3
1.3
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
64
287
2.26
8.45
6.9
2.6
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
24
62
3.90
8.42
1.2
1.3
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
415
3118
1.40
8.38
1.3
1.3
u/ml
7.9
10.9
0.54
158
1301
(3005322) IgE [Units/volume] in Serum or Plasma
201
1309
1.59
8.27
1.4
1.3
u/ml
224.1
213.0
0.06
186
1219
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
522
4082
1.36
8.24
2.8
3.0
ng/l
1546.0
1092.9
0.95
438
3421
(21494815) CD4 cells/100 lymphocytes in Specimen
42
157
2.71
8.16
1.5
2.3
%
41.6
44.3
—
7
22
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
38
135
2.84
8.12
2.0
2.5
e6/l
436.6
572.3
0.82
28
118
(3042733) HLA Ab [Presence] in Serum
27
78
3.49
8.09
1.6
4.9
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
117
663
1.80
8.09
2.4
1.9
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
10
11
9.13
8.09
1.3
1.1
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
502
3918
1.36
8.00
4.6
3.6
kg/l
1.0
1.0
0.00
107
542
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
72
348
2.10
7.93
1.7
1.6
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
63
289
2.21
7.91
4.4
3.0
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
139
834
1.71
7.89
1.9
2.0
u/l
39.9
40.0
0.01
124
758
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
37
132
2.83
7.86
2.0
1.9
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
74
363
2.07
7.84
3.6
2.3
g/l
125.8
131.8
1.40
62
266
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
104
574
1.85
7.84
2.7
2.9
g/l
3.3
3.5
0.73
99
542
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
67
317
2.15
7.79
1.5
1.5
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
1963
18463
1.39
7.79
26.2
12.7
%
38.3
40.6
15.43
1402
14396
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
414
3171
1.37
7.38
3.7
3.4
ng/l
260.4
490.0
1.66
265
2216
(21494814) CD8 cells/100 lymphocytes in Specimen
22
59
3.75
7.35
1.2
2.1
—
—
—
0
0
(3010421) pH of Blood
85
450
1.92
7.30
4.4
4.0
ph
7.4
7.4
0.61
80
376
(3018405) Lactate [Moles/volume] in Arterial blood
102
574
1.81
7.25
3.9
4.3
mmol/l
1.4
1.4
0.06
97
566
(3022621) pH of Urine by Test strip
174
1135
1.58
7.12
4.3
2.5
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
186
1234
1.55
7.07
2.1
2.7
g/l
67.2
66.9
0.17
179
1140
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
47
200
2.38
7.05
2.0
2.3
pg
31.4
32.3
0.58
47
200
(3051651) Icteric interference index of Serum or Plasma
32
114
2.83
6.85
6.3
3.4
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
1561
14310
1.27
6.80
3.2
3.3
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
104
601
1.76
6.78
2.1
1.8
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
35
132
2.68
6.74
1.6
1.9
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
88
488
1.83
6.59
1.7
1.7
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
422
3305
1.34
6.46
1.3
1.3
iu/ml
17.2
29.6
3.32
138
1021
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
43
186
2.34
6.26
1.0
1.0
—
—
—
0
0
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
34
132
2.60
6.21
2.0
2.6
e9/l
0.2
0.2
0.10
26
118
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
37
150
2.49
6.19
2.1
1.6
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
37
150
2.49
6.19
2.1
1.6
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
37
150
2.49
6.19
2.1
1.6
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
32
121
2.67
6.16
1.2
1.1
—
—
—
0
0
(3002256) Pathology report gross observation
302
2261
1.39
6.15
1.3
1.2
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
90
514
1.78
6.14
2.0
2.2
mg/l
10.8
10.5
0.10
82
478
(3003694) ABO and Rh group [Type] in Blood
676
5677
1.27
6.07
1.6
1.5
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
25
83
3.03
6.07
2.2
1.9
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
25
83
3.03
6.07
2.2
1.9
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
25
83
3.03
6.07
2.2
1.9
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
25
83
3.03
6.07
2.2
1.9
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
51
243
2.12
5.91
2.0
1.6
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
74
406
1.85
5.77
1.5
2.4
nmol/l
0.9
0.8
0.37
63
351
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
95
564
1.71
5.69
1.1
1.1
u/ml
0.7
3.9
—
8
82
(3003181) Sodium [Moles/volume] in Urine
51
247
2.09
5.68
2.0
1.4
mmol/l
68.7
66.1
0.11
31
207
(40760888) Immunoglobulin light chains.free panel - Serum
60
311
1.95
5.56
2.0
3.8
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
172
1186
1.49
5.50
3.4
2.8
ng/l
283.1
169.6
1.40
159
1062
(3004588) Protein electrophoresis panel - Serum or Plasma
149
999
1.52
5.45
1.8
2.4
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
79
453
1.77
5.36
1.3
1.4
—
—
—
0
0
(3022313) Gas panel - Capillary blood
120
772
1.58
5.28
6.5
3.7
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
98
600
1.66
5.26
3.0
3.3
g/l
0.2
0.3
0.22
54
271
(40768443) Skin Pathology biopsy report
112
710
1.61
5.24
1.3
1.2
—
—
—
0
0
(44806118)
45
215
2.11
5.22
1.5
1.6
—
—
—
0
0
(44790047)
45
215
2.11
5.22
1.5
1.6
—
—
—
0
0
(44790048)
45
215
2.11
5.22
1.5
1.6
—
—
—
0
0
(44790049)
45
215
2.11
5.22
1.5
1.6
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
31
126
2.48
5.21
2.8
2.2
u/field
1.8
2.1
0.17
16
63
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
143
961
1.52
5.19
2.1
2.3
u/l
5120.0
4686.8
0.05
47
377
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
518
4287
1.27
5.15
1.6
1.6
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
82
484
1.72
5.05
4.2
4.5
mmol/l
3.9
3.9
0.17
77
452
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
31
129
2.42
4.97
2.0
1.6
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
555
4652
1.25
4.92
3.0
2.5
umol/l
6986.6
4258.2
0.66
506
4112
(3024471) HLA-A [Type]
22
77
2.87
4.92
1.0
1.0
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
70
400
1.77
4.84
1.3
1.2
u/ml
46.0
41.7
—
6
35
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
19
62
3.08
4.79
2.2
3.1
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
36
164
2.21
4.72
2.9
1.5
g/l
0.9
1.0
1.17
36
164
(3051611) Lipemic interference index of Serum or Plasma
35
158
2.23
4.69
6.2
3.3
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
40
191
2.11
4.68
1.9
1.8
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
40
192
2.10
4.62
2.7
2.7
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
41
199
2.08
4.60
2.0
1.7
—
—
—
0
0
(3024932) HLA-DR beta [Type]
21
75
2.82
4.55
1.0
1.1
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
323
2561
1.30
4.47
1.4
1.4
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
582
4955
1.23
4.43
4.7
4.1
mg/mmol
8.1
9.4
0.36
405
3215
(3037692) Legionella sp identified in Specimen by Organism specific culture
18
60
3.02
4.40
1.3
1.8
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
195
1438
1.39
4.38
4.8
2.4
ml/min/173m2
63.7
72.4
2.96
97
532
(21494755) Public health laboratory ask at order entry panel
198
2625
0.73
4.26
1.3
1.3
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
71
424
1.70
4.25
1.9
3.6
mg/l
37.5
51.8
0.46
51
336
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
47
249
1.91
4.17
1.2
1.2
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
65
382
1.72
4.13
1.2
1.2
u/ml
10.7
4.4
—
5
26
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
47
251
1.89
4.08
1.7
1.6
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
49
266
1.86
4.05
2.3
2.5
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
69
416
1.68
4.00
1.9
3.6
ratio
1.3
3.2
—
7
33
(3034860) Kappa light chains.free [Mass/volume] in Serum
70
424
1.67
3.99
2.0
3.7
mg/l
54.5
68.1
0.37
52
336
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
86
549
1.59
3.98
1.3
2.3
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
86
549
1.59
3.98
1.3
2.3
g/l
4.0
3.8
1.00
46
404
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
86
549
1.59
3.98
1.3
2.3
g/l
7.4
7.3
0.21
50
423
(3006270) Folate [Moles/volume] in Blood
30
138
2.19
3.89
1.2
1.1
nmol/l
344.2
399.0
0.84
23
129
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
36
179
2.03
3.84
2.2
1.8
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
65
391
1.68
3.82
1.9
1.7
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
112
766
1.49
3.81
1.4
1.3
miu/ml
197.9
219.3
0.22
42
374
(3004616) Nuclear Ab [Presence] in Serum
42
222
1.91
3.78
1.4
1.2
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
77
488
1.60
3.70
1.3
1.2
u/ml
5.7
7.1
0.20
11
78
(3003740) Influenza virus B Ag [Presence] in Specimen
66
403
1.66
3.68
1.0
1.1
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
76
481
1.60
3.67
1.3
1.2
u/ml
7.7
2.5
—
6
48
(40761535) Cells panel - Urine sediment
182
1369
1.36
3.65
3.5
3.1
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
16
56
2.87
3.63
1.3
1.4
ug/l
12.7
8.8
0.93
16
56
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
7
9
7.80
3.56
1.0
1.1
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
1557
14681
1.18
3.51
3.9
3.8
pmol/l
14.7
14.6
0.91
1446
13555
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
63
386
1.65
3.48
1.2
1.2
—
10.9
—
0
5
(3003338) MCHC [Mass/volume]
1802
17214
1.20
3.48
32.2
15.0
g/l
332.1
333.5
7.86
1793
17080
(3000060) B lymphocytes [#/volume] in Blood
15
52
2.90
3.46
1.5
2.2
e6/l
234.0
178.0
—
5
30
(3002523) Influenza virus A Ag [Presence] in Specimen
65
404
1.63
3.40
1.0
1.1
—
—
—
0
0
(3011325) HIV 1+2 Ab [Presence] in Serum
7
10
7.02
3.36
1.0
1.0
—
—
—
0
0
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
140
1024
1.39
3.36
12.5
10.5
%
0.7
0.7
0.16
135
1019
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
140
1028
1.38
3.28
12.0
10.3
%
1.3
1.4
1.18
135
1023
(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay
6
7
8.59
3.26
1.0
1.0
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
15
54
2.79
3.25
1.1
1.1
—
—
—
0
0
(3004451) EKG impression Narrative
19
78
2.45
3.21
1.7
1.3
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
12
38
3.17
3.21
1.1
1.1
%
105.3
95.1
0.91
12
38
(40761539) Cells [Type] in Urine sediment by Light microscopy
12
38
3.17
3.21
1.2
1.0
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
12
38
3.17
3.21
1.1
1.1
—
—
—
0
0
(3022493) Free Hemoglobin [Mass/volume] in Plasma
18
72
2.51
3.21
1.0
6.1
mg/l
12909.5
77.5
0.47
13
57
(3004775) Volume in Urine collected for unspecified duration
28
137
2.06
3.16
2.5
2.4
ml
726.9
625.1
0.33
21
95
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
77
508
1.53
3.16
1.4
2.4
g/l
10.7
10.3
0.28
65
437
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
85
574
1.50
3.13
2.4
2.8
%
199.8
175.1
1.92
80
551
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
34
180
1.90
3.10
1.8
1.6
%
44.4
57.5
0.88
18
116
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
53
325
1.65
2.97
1.1
1.1
iu/ml
67.6
1615.1
—
7
83
(3047352) Trisomy 18 risk [Likelihood] in Fetus
31
561
0.55
2.90
1.4
1.4
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
29
149
1.96
2.90
2.0
2.6
e6/l
752.6
768.2
0.03
18
60
(3024891) Influenza virus A+B Ag [Presence] in Specimen
82
560
1.48
2.89
1.1
1.1
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
17
70
2.44
2.88
2.5
2.0
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
17
70
2.44
2.88
2.5
2.0
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
31
558
0.55
2.86
1.4
1.4
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
12
41
2.94
2.86
1.1
1.1
—
—
—
0
0
(3020891) Body temperature
90
628
1.45
2.85
6.6
4.9
—
—
—
0
0
(3017704) Immunofixation for Urine
19
83
2.30
2.84
1.7
1.6
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
34
186
1.84
2.83
2.4
6.5
mmol/l
6.3
7.2
0.90
24
155
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
21
96
2.20
2.83
1.0
1.2
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
17
71
2.40
2.80
2.5
2.0
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
41
677
0.60
2.76
1.4
1.4
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
18
78
2.32
2.74
1.2
1.2
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
41
676
0.60
2.74
1.4
1.4
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
112
1510
0.73
2.74
1.4
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
41
674
0.60
2.71
1.4
1.4
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
30
160
1.89
2.71
1.3
1.3
u/ml
0.4
0.6
0.31
11
68
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
115
847
1.38
2.70
13.5
11.1
mmol/l
23.4
24.3
1.95
108
804
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
41
672
0.60
2.68
1.4
1.4
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
1818
17499
1.17
2.67
4.7
4.5
mu/l
1.7
2.1
1.81
1702
16274
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
9
24
3.76
2.67
2.0
1.2
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
537
4737
1.17
2.66
3.4
3.3
mg/l
470.1
332.3
0.28
362
3077
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
90
637
1.43
2.66
2.0
2.5
%
87.8
93.0
1.23
85
597
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
24
119
2.03
2.66
1.0
1.5
u/l
4.8
6.4
1.36
19
98
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
10
32
3.13
2.64
1.7
1.6
—
—
—
0
0
(3000012) Reticulocyte production index
17
74
2.31
2.58
1.1
1.8
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
25
128
1.96
2.55
1.1
1.2
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
34
575
0.59
2.53
1.4
1.5
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
18
82
2.20
2.47
1.2
1.1
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
60
883
0.67
2.44
1.4
1.7
mg/l
3.1
4.2
0.67
40
616
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
282
3328
0.83
2.36
2.9
2.8
ug/l
0.7
0.7
0.28
197
2028
(3044889) 12 lead EKG panel
1344
12714
1.13
2.36
3.7
3.4
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
21
105
2.01
2.30
1.2
1.4
nmol/l
145.3
138.1
0.23
21
105
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
9
28
3.22
2.30
2.0
2.1
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
22
112
1.97
2.30
2.0
1.6
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
80
573
1.41
2.26
2.0
2.4
ug/l
307.1
300.7
0.02
68
540
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
17
79
2.16
2.24
1.1
1.1
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
45
287
1.58
2.23
2.2
1.8
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
39
240
1.64
2.23
1.7
1.6
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
118
903
1.32
2.21
1.5
1.6
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
19
93
2.05
2.21
1.7
3.1
u/ml
864.7
1224.9
0.45
19
93
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
5
9
5.56
2.21
1.0
5.7
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
21
107
1.97
2.20
1.3
1.2
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
460
4072
1.16
2.16
3.9
3.3
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
343
2966
1.18
2.16
1.8
1.9
%
1.4
1.4
1.35
290
2662
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
50
741
0.67
2.15
1.4
1.5
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
182
2222
0.80
2.14
1.6
1.7
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
32
189
1.70
2.13
2.7
2.1
mg/l
19.0
23.2
—
10
53
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
8
25
3.21
2.09
1.5
3.1
—
—
—
0
0
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
5
10
5.01
2.07
1.4
3.4
—
—
—
0
0
(4038314)
7
20
3.51
2.05
1.1
1.2
—
—
—
0
0
(21494434) Karyotype in Bone marrow
26
147
1.78
2.02
1.0
1.3
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
44
289
1.53
1.95
1.8
1.7
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
62
437
1.43
1.95
1.4
1.4
—
—
—
0
0
(3011985) Renin [Units/volume] in Plasma
34
210
1.63
1.95
1.8
1.4
mu/l
119.2
37.2
1.35
29
187
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
14
64
2.19
1.94
1.0
1.1
—
—
—
0
0
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
5
11
4.55
1.94
1.0
1.4
u/l
3.8
13.7
—
5
11
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
25
142
1.77
1.93
1.1
1.1
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
15
71
2.12
1.92
1.6
1.7
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
34
212
1.61
1.88
1.0
1.2
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
595
5417
1.13
1.85
3.4
3.3
mmol/l
8.4
8.1
0.90
510
4639
(36660697) Celiac disease serology panel - Serum
187
1553
1.22
1.84
1.2
1.2
—
—
—
0
0
(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis
5
12
4.17
1.82
1.0
1.5
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
48
327
1.48
1.82
1.3
1.5
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
17
87
1.96
1.79
1.2
1.1
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
366
3240
1.15
1.73
1.7
1.5
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
7
24
2.92
1.72
1.3
2.0
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
18
96
1.88
1.70
2.2
1.6
—
—
—
0
0
(3038026) Centromere Ab [Units/volume] in Serum
24
141
1.71
1.68
1.2
1.1
—
86.1
—
0
9
(3001019) Free T4 and TSH panel - Serum or Plasma
103
1300
0.78
1.66
1.7
1.6
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
404
4502
0.88
1.66
4.0
3.8
%
19.4
21.3
1.87
199
1935
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
47
326
1.45
1.65
1.0
1.0
u/ml
0.9
2.4
3.24
15
160
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
25
150
1.67
1.63
1.9
1.4
%
40.6
34.6
0.31
15
96
(3023419) Bacteria identified in Sputum by Culture
33
213
1.56
1.62
3.8
2.5
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
10
43
2.33
1.60
1.0
1.2
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
98
1237
0.78
1.60
1.2
1.2
—
—
—
0
0
(4010399)
148
1221
1.23
1.59
1.3
1.4
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
25
152
1.65
1.56
6.0
3.0
mg/l
41.6
39.4
0.03
20
115
(3051387) C reactive protein [Mass/volume] in Capillary blood
53
381
1.40
1.55
3.8
3.7
mg/l
21.4
24.3
0.39
42
240
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
14
71
1.98
1.54
2.1
2.6
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
63
838
0.74
1.52
1.4
1.4
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
5
15
3.34
1.52
1.0
1.3
—
—
—
0
0
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
23
138
1.67
1.51
1.1
1.1
—
33.0
—
0
7
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
32
209
1.54
1.51
1.1
1.3
nmol/l
—
—
—
0
0
(3005082) Progesterone [Moles/volume] in Serum or Plasma
5
126
0.40
1.49
1.4
1.3
nmol/l
45.1
31.7
—
5
106
(3045414) Leukocytes [Presence] in Urine
100
797
1.27
1.47
1.7
1.7
—
—
—
0
0
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
23
140
1.65
1.45
1.1
1.2
—
61.5
—
0
10
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
18
102
1.77
1.44
1.1
1.2
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
45
319
1.42
1.44
1.5
1.7
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
5
16
3.13
1.44
1.0
1.0
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
44
311
1.42
1.43
1.4
1.4
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
7
154
0.45
1.42
1.7
3.4
—
—
—
0
0
(3020874) Milk IgE Ab [Units/volume] in Serum
22
134
1.65
1.39
1.0
1.1
u/ml
0.9
2.7
—
6
42
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
17
96
1.78
1.39
2.2
1.6
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
68
520
1.32
1.38
1.3
2.4
g/l
3.1
3.1
0.19
48
412
(3027456) Digoxin [Moles/volume] in Serum or Plasma
35
239
1.47
1.37
2.2
3.1
nmol/l
0.8
0.8
0.54
25
183
(3048879) Bone marrow aspiration report
9
41
2.20
1.37
2.6
2.6
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
6
23
2.61
1.36
1.0
1.2
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
320
2859
1.14
1.35
3.4
2.8
mmol/l
2.4
2.4
0.88
270
2527
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
0
37
0.00
1.34
0.0
1.1
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
38
0.00
1.34
0.0
1.2
—
—
—
0
0
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
14
76
1.85
1.29
1.9
3.2
umol/l
98.7
110.6
—
7
43
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
8
34
2.36
1.29
1.4
1.3
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
27
177
1.53
1.29
1.0
1.1
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
23
146
1.58
1.26
1.1
1.1
—
—
—
0
0
(3012494) Peanut IgE Ab [Units/volume] in Serum
12
63
1.91
1.22
1.0
1.1
u/ml
0.5
1.7
—
5
36
(3036489) Thrombin time
90
727
1.25
1.22
2.1
2.3
s
22.4
21.3
0.50
83
640
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
159
1360
1.18
1.22
2.3
2.4
au/ml
7.3
22.9
—
6
101
(3001964) Herpes simplex virus Ag [Presence] in Specimen
11
56
1.97
1.22
1.4
1.7
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
107
1288
0.82
1.19
1.4
1.5
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
30
427
0.70
1.16
1.4
1.6
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
8
39
2.05
1.15
19.4
5.6
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
36
0.00
1.14
0.0
1.1
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
155
1796
0.85
1.13
2.0
2.0
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
11
58
1.90
1.12
2.5
2.4
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
7
137
0.51
1.09
1.3
2.2
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
5
21
2.38
1.09
1.0
1.0
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
5
21
2.38
1.09
1.0
1.0
—
—
—
0
0
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
40
295
1.36
1.08
1.7
1.9
—
1018.2
—
0
11
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
34
244
1.40
1.07
1.1
1.3
nmol/l
—
0.4
—
0
18
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
42
313
1.35
1.06
1.1
1.1
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
77
944
0.81
1.05
1.7
1.6
mu/l
320.6
287.2
0.34
72
859
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
71
570
1.25
1.05
1.2
1.1
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
74
597
1.25
1.05
1.5
1.3
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
103
861
1.21
1.05
2.4
1.8
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
9
46
1.96
1.03
1.2
1.3
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
5
22
2.28
1.03
2.0
2.6
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
11
60
1.84
1.02
16.5
14.3
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
88
727
1.22
1.01
1.4
1.4
u/l
8.8
8.4
0.08
75
602
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
10
53
1.89
1.01
1.3
1.1
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
10
53
1.89
1.01
1.3
1.1
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
23
155
1.49
1.01
1.4
2.1
—
—
—
0
0
(3006442) Creatine [Moles/volume] in Serum or Plasma
22
147
1.50
1.00
2.5
1.4
—
65.3
—
0
14
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
86
710
1.22
1.00
1.7
1.4
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
7
35
2.00
1.00
1.0
1.1
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
7
35
2.00
1.00
1.0
1.1
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
7
35
2.00
1.00
1.0
1.1
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
232
2585
0.89
0.99
1.6
1.7
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
231
2069
1.13
0.98
3.9
4.0
%
32.6
31.4
0.92
185
1474
(3011288) Drugs identified in Urine by Screen method
67
826
0.81
0.98
1.5
3.4
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
5
23
2.18
0.98
1.0
1.0
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
5
23
2.18
0.98
2.2
1.5
ng/l
120.0
108.4
—
5
23
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
5
23
2.18
0.98
1.0
1.0
—
—
—
0
0
(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum
0
30
0.00
0.97
0.0
1.0
—
0.1
—
0
18
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
31
224
1.39
0.96
1.1
1.4
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
9
51
1.77
0.94
4.4
2.4
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
9
51
1.77
0.94
4.4
2.4
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
131
1132
1.17
0.94
1.4
1.4
iu/l
28.0
24.5
0.56
121
953
(3028707) Methadone [Presence] in Urine by Screen method
41
531
0.77
0.91
1.4
3.2
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
19
126
1.51
0.91
1.9
2.9
%
35.5
43.7
—
8
39
(3045683) HLA typing for celiac disease panel - Blood or Tissue
20
135
1.49
0.89
1.1
1.0
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
10
56
1.79
0.87
1.1
1.1
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
10
56
1.79
0.87
1.3
1.1
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
28
203
1.38
0.87
1.8
1.4
pmol/l
510.0
293.3
0.60
22
160
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
6
30
2.00
0.87
1.2
1.2
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
50
396
1.27
0.86
1.7
1.7
e6/l
9942.5
14559.6
0.55
40
292
(3022689) Creatine [Moles/volume] in Urine
8
44
1.82
0.86
2.6
1.3
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
12
72
1.67
0.85
1.6
1.6
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
6
31
1.94
0.84
1.3
1.4
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
1906
19347
0.92
0.84
4.6
4.3
mmol/l
2.7
2.8
4.88
1786
18102
(3023410) Appearance of Cerebral spinal fluid
14
215
0.65
0.84
2.1
1.6
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
78
929
0.83
0.84
1.3
2.4
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
95
1111
0.85
0.83
1.3
2.4
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
43
545
0.79
0.83
2.0
1.7
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
58
472
1.23
0.81
1.3
2.6
g/l
1.0
1.0
0.01
52
421
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
26
189
1.38
0.81
2.2
1.7
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
124
1415
0.87
0.80
1.8
1.9
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
31
233
1.33
0.79
1.1
1.1
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
24
0.00
0.79
0.0
1.2
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
6
33
1.82
0.79
1.3
2.1
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
20
140
1.43
0.77
3.2
2.3
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
28
0.00
0.76
0.0
1.1
—
—
—
0
0
(3012565) Volume of 24 hour Urine
14
91
1.54
0.75
2.2
2.7
ml
1815.7
2177.0
0.75
14
83
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
11
67
1.64
0.75
1.0
1.0
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
17
116
1.47
0.74
1.1
1.2
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
21
150
1.40
0.73
1.1
1.1
—
—
—
0
0
(44806420)
7
39
1.80
0.72
2.1
2.5
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
13
84
1.55
0.72
1.2
1.2
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
137
1217
1.13
0.71
3.6
3.4
pmol/l
4.4
4.6
1.26
122
1091
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
147
1312
1.13
0.71
2.6
2.2
ug/l
5.3
7.6
1.14
137
1188
(3008536) Aspergillus sp Ab [Presence] in Serum
7
40
1.75
0.71
3.0
1.8
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
5
26
1.93
0.70
1.6
1.3
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
5
26
1.93
0.70
1.4
1.4
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
7
41
1.71
0.70
1.0
1.1
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
9
58
1.55
0.69
5.8
4.3
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
9
143
0.63
0.69
1.6
1.3
—
1.4
—
0
6
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
50
409
1.23
0.69
2.8
2.5
ug/min
47.1
135.6
2.38
33
263
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
39
310
1.26
0.69
1.4
1.6
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
13
85
1.53
0.69
2.2
1.7
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
9
59
1.53
0.68
1.3
1.2
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
5
28
1.79
0.66
1.6
1.2
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
103
1169
0.88
0.65
1.2
2.3
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
7
44
1.59
0.65
1.0
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
7
44
1.59
0.65
1.0
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
7
44
1.59
0.65
1.0
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
7
44
1.59
0.65
1.0
1.1
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
5
29
1.73
0.64
7.4
7.0
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
10
63
1.59
0.61
2.6
1.3
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
105
1184
0.88
0.61
1.2
2.4
—
—
—
0
0
(3042552) Rheumatoid factor [Units/volume] in Pleural fluid
0
20
0.00
0.60
0.0
1.0
—
9.1
—
0
8
(4024509)
19
139
1.37
0.60
1.3
1.4
—
—
—
0
0
(4034850)
71
611
1.17
0.60
13.3
8.5
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
0
22
0.00
0.59
0.0
1.2
—
—
—
0
0
(3035880) pH of Pleural fluid
11
72
1.53
0.59
1.1
1.3
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
26
201
1.30
0.59
1.1
1.1
—
—
—
0
0
(3019174) dRVVT (LA screen)
0
23
0.00
0.58
0.0
1.1
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
13
89
1.46
0.58
1.2
1.1
iu/ml
153.7
184.7
0.29
13
89
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
35
283
1.24
0.56
1.3
1.4
mmol/l
7.4
7.2
0.13
28
205
(3028300) Cannabinoids [Presence] in Urine
107
1197
0.89
0.56
1.3
2.3
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
5
86
0.58
0.56
1.0
1.1
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
1689
17138
0.95
0.55
6.2
5.0
mmol/mol
39.9
39.0
2.89
1589
16098
(40768800) Prostate Pathology biopsy report
24
307
0.78
0.55
1.3
1.2
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
24
186
1.29
0.54
1.3
1.4
mmol/l
11.1
12.8
—
5
46
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
12
82
1.47
0.54
1.3
1.1
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
9
60
1.50
0.54
1.3
1.1
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
6
39
1.54
0.53
1.2
1.1
—
—
—
0
0
(44813793)
18
134
1.35
0.53
1.1
1.0
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
107
1191
0.89
0.53
1.3
2.2
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
20
152
1.32
0.52
1.2
1.3
e6/l
45696.0
87665.7
0.40
11
103
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
6
40
1.50
0.51
1.2
1.3
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
6
40
1.50
0.51
1.5
1.5
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
9
135
0.67
0.51
1.6
1.9
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
43
510
0.84
0.51
2.4
2.0
iu/l
3.7
4.7
0.50
23
190
(3021788) Differential panel - Synovial fluid
36
297
1.22
0.50
1.8
1.6
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
6
41
1.46
0.50
7.5
6.4
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
40
476
0.84
0.49
1.4
1.5
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
464
4847
0.95
0.49
1.9
1.6
mmol/l
1.5
1.4
0.45
399
4156
(4015189)
7
45
1.56
0.49
1.9
2.8
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
7
46
1.52
0.48
1.7
2.1
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
1879
18988
0.95
0.48
4.3
4.0
mmol/l
1.4
1.4
0.38
1763
17804
(4211845)
11
77
1.43
0.45
4.4
2.5
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
5
85
0.59
0.45
1.4
1.1
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
15
112
1.34
0.44
1.2
1.2
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
11
78
1.41
0.43
1.0
1.0
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
9
131
0.69
0.43
1.0
1.1
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
17
218
0.78
0.42
1.2
1.0
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
5
32
1.56
0.42
1.0
1.3
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
8
57
1.40
0.42
1.4
1.1
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
19
149
1.28
0.41
1.2
1.2
—
—
—
0
0
(3038864) risperiDONE [Moles/volume] in Serum or Plasma
0
16
0.00
0.41
0.0
1.5
—
16.3
—
0
16
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
0
17
0.00
0.40
0.0
1.2
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
69
772
0.89
0.40
1.9
1.8
nmol/l
38.5
38.3
0.02
69
751
(3001686) Cold agglutinin [Titer] in Serum or Plasma
5
35
1.43
0.39
1.0
1.2
—
226.4
—
0
5
(3032352) Blasts [#/volume] in Cerebral spinal fluid
0
19
0.00
0.39
0.0
2.3
—
—
—
0
0
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
24
196
1.23
0.39
1.2
1.4
pmol/l
100.2
75.4
—
10
62
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
11
148
0.74
0.38
1.2
1.1
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
21
258
0.81
0.38
5.2
3.7
u/ml
17.3
29.7
1.40
21
253
(3006462) Nitrate [Presence] in Urine
9
67
1.34
0.38
3.9
2.6
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
5
37
1.35
0.37
1.0
1.2
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
549
5667
0.96
0.37
4.6
4.3
ug/l
3.9
2.2
0.56
504
5109
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
11
146
0.75
0.36
1.2
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
11
146
0.75
0.36
1.2
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
11
146
0.75
0.36
1.2
1.1
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
11
146
0.75
0.36
1.1
1.7
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
13
99
1.31
0.35
2.4
1.8
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
1815
18315
0.96
0.35
4.0
3.6
mmol/l
1.3
1.3
0.69
1702
17107
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
37
320
1.16
0.34
1.0
1.1
—
—
—
0
0
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
23
191
1.21
0.33
1.5
1.6
mmol/l
7.1
7.5
0.46
15
118
(3044290) Cell count panel - Cerebral spinal fluid
48
425
1.13
0.33
1.7
1.4
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
11
144
0.76
0.33
1.2
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
11
144
0.76
0.33
1.2
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
11
144
0.76
0.33
1.2
1.1
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
6
46
1.31
0.33
2.0
1.9
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
25
296
0.84
0.33
1.3
1.2
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
39
445
0.87
0.33
1.2
1.1
u/ml
0.6
2.4
—
7
115
(3024928) Oxygen saturation in Venous blood
41
361
1.14
0.31
5.3
2.7
—
—
—
0
0
(4133840)
7
56
1.25
0.29
1.4
1.1
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
222
2322
0.95
0.28
1.5
1.8
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
36
317
1.14
0.28
1.2
1.2
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
14
112
1.25
0.28
1.4
2.1
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
42
468
0.90
0.26
1.1
1.1
u/ml
9.2
5.8
0.42
16
255
(3014133) Dog dander IgE Ab [Units/volume] in Serum
42
377
1.12
0.25
1.1
1.1
u/ml
1.2
3.6
2.18
11
151
(4146454)
19
160
1.19
0.25
2.0
2.8
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
48
435
1.11
0.25
1.2
2.4
g/l
38.9
38.1
0.43
42
380
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
13
105
1.24
0.24
1.2
1.1
—
—
—
0
0
(3000492) Spirometry study
210
2017
1.05
0.23
1.4
1.4
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
310
3200
0.96
0.23
1.9
2.1
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
5
38
1.32
0.23
7.4
6.3
—
—
—
0
0
(4198724)
10
125
0.80
0.23
1.6
3.5
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
18
153
1.18
0.22
2.9
4.5
—
—
—
0
0
(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.4
—
1.7
—
0
11
(3007700) Barley IgE Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.1
—
0.1
—
0
6
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
2.0
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
13
156
0.83
0.21
1.1
1.8
—
—
—
0
0
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
85
799
1.07
0.21
2.4
2.3
—
—
—
0
0
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3013762) Body weight Measured
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
14
117
1.20
0.20
1.1
1.2
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
19
164
1.16
0.20
1.3
1.2
—
—
—
0
0
(3033942) Copper [Moles/time] in 24 hour Urine
0
14
0.00
0.20
0.0
1.1
—
0.2
—
0
5
(4212803)
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3007542) Rye IgE Ab [Units/volume] in Serum
0
14
0.00
0.20
0.0
1.1
—
0.2
—
0
6
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
66
707
0.93
0.20
1.4
1.5
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
11
90
1.22
0.19
1.3
1.7
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
11
90
1.22
0.19
1.3
1.7
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
280
2879
0.97
0.18
1.8
2.0
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
29
321
0.90
0.18
1.1
1.6
—
—
—
0
0
(3036603) Volume of Urine
14
119
1.18
0.17
2.1
1.5
ml
1634.0
1947.7
—
8
20
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
7
62
1.13
0.17
1.0
1.0
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
41
444
0.92
0.17
1.1
1.1
u/ml
0.2
1.6
2.17
11
189
(3014271) Vancomycin [Susceptibility]
7
63
1.11
0.17
2.1
2.4
—
—
—
0
0
(4027681)
17
148
1.15
0.17
1.3
1.3
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
19
215
0.88
0.16
1.9
1.4
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
8
68
1.18
0.16
1.0
1.1
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
152
1465
1.04
0.16
1.2
1.2
iu/ml
102.6
141.0
0.64
61
559
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
22
246
0.89
0.16
1.2
1.1
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
8
71
1.13
0.16
1.6
1.1
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
15
130
1.15
0.15
1.7
1.3
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
14
161
0.87
0.15
1.1
1.1
—
—
—
0
0
(3024263) Appearance of Synovial fluid
7
88
0.79
0.14
3.6
1.7
—
—
—
0
0
(4094501)
45
481
0.93
0.14
1.1
1.1
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
10
118
0.85
0.14
1.4
1.4
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
8
100
0.80
0.13
1.7
1.5
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
14
159
0.88
0.13
1.4
1.5
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
20
180
1.11
0.13
1.0
1.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
36
335
1.08
0.13
1.4
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
36
335
1.08
0.13
1.4
1.3
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
9
110
0.82
0.13
1.6
1.4
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
1903
19091
0.98
0.11
4.4
4.0
mmol/l
4.6
4.7
2.86
1794
17992
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
36
339
1.06
0.10
1.1
1.1
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
28
262
1.07
0.09
1.4
1.6
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
208
2042
1.02
0.09
8.3
6.0
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
6
55
1.09
0.09
1.0
1.9
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
46
439
1.05
0.09
1.2
1.2
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
36
341
1.06
0.08
1.2
1.2
u/ml
7.5
3.6
0.56
21
115
(3029396) Erythrocyte agglutination [Presence] in Blood
6
58
1.03
0.08
2.2
3.3
—
—
—
0
0
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
11
123
0.89
0.08
1.0
1.1
—
4.8
—
0
26
(3047189) Immunofixation for 24 hour Urine
6
71
0.84
0.07
1.5
1.7
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
78
757
1.03
0.07
1.7
1.7
—
—
—
0
0
(21491868) Cryoglobulin [Mass/volume] in Serum
8
74
1.08
0.07
1.1
1.1
—
0.0
—
0
5
(3012441) Differential panel - Pleural fluid
15
137
1.10
0.07
1.3
1.4
—
—
—
0
0
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
20
186
1.08
0.07
1.2
1.2
mg/l
35.3
43.8
0.51
15
153
(3023511) Choriogonadotropin [Units/volume] in Urine
52
538
0.97
0.06
1.4
1.3
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
112
1097
1.02
0.06
1.0
1.1
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
13
141
0.92
0.05
1.2
1.5
—
—
—
0
0
(3020491) Glucose [Moles/volume] in Blood
16
149
1.07
0.05
1.4
2.0
mmol/l
7.4
6.6
—
10
102
(3038177) Helicobacter pylori Ab [Presence] in Serum
35
364
0.96
0.05
1.5
1.2
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
30
287
1.05
0.05
1.3
1.2
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
170
1722
0.99
0.05
2.5
2.2
nmol/l
12.6
13.2
0.46
156
1562
(3014051) Protein [Presence] in Urine by Test strip
40
387
1.03
0.04
2.2
2.0
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
69
704
0.98
0.04
1.9
1.8
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
20
210
0.95
0.03
1.2
1.1
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
39
379
1.03
0.03
1.3
1.5
nmol/l
0.4
0.4
0.11
33
301
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
18
189
0.95
0.03
4.7
4.9
u/ml
12.6
91.6
—
8
55
(3023430) Cat dander IgE Ab [Units/volume] in Serum
34
350
0.97
0.03
1.1
1.1
u/ml
2.5
5.1
1.16
12
146
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
17
178
0.95
0.02
1.2
1.1
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
11
117
0.94
0.01
6.9
6.9
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
34
332
1.02
0.01
1.2
1.3
u/ml
6.2
5.1
0.23
21
152
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
49
498
0.98
0.01
1.2
1.1
u/ml
2.0
1.5
0.09
11
208
(1761868) Lipid panel - Serum or Plasma
766
7648
1.00
0.01
3.3
2.5
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
46
453
1.02
0.01
1.6
1.4
e6/l
53.4
23.1
0.38
39
354
(4306422)
34
334
1.02
0.00
1.1
1.2
—
—
—
0
0
(3015076) Soybean IgE Ab [Units/volume] in Serum
13
135
0.96
0.00
1.1
1.1
—
4.0
—
0
21
(40768793) Breast Pathology biopsy report
39
389
1.00
0.00
1.2
1.2
—
—
—
0
0
(1002224) Polysomnography panel
99
995
0.99
0.00
1.1
1.1
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
61
609
1.00
0.00
1.4
1.5
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
12
116
1.03
0.00
1.4
1.1
—
—
—
0
0
(4281824)
17
168
1.01
0.00
1.0
1.1
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
1827
18266
1.00
0.00
4.2
4.0
mmol/l
5.9
5.9
0.68
1695
16915
(3044941) Cell count panel - Synovial fluid
27
267
1.01
0.00
1.3
1.4
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
57
573
0.99
0.00
2.8
2.6
—
—
—
0
0
(4268621)
23
233
0.99
0.00
2.2
2.3
—
—
—
0
0
(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine
0
6
0.00
0.00
0.0
1.0
—
1500.8
—
0
6
(3022725) Serotonin [Moles/volume] in Serum
0
7
0.00
0.00
0.0
2.0
—
1067.6
—
0
7
(3044242) Glucose [Moles/volume] in Arterial blood
8
88
0.91
0.00
1.6
2.5
—
—
—
0
0
(3002079) Sodium [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.2
—
118.8
—
0
5
(43055514) Macroprolactin [Presence] in Serum or Plasma
5
58
0.86
0.00
1.2
1.5
—
—
—
0
0
(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3007302) Hemoglobin [Mass/volume] in Mixed venous blood
0
8
0.00
0.00
0.0
4.5
—
—
—
0
0
(3046682) IgA [Presence] in Skin by Immunofluorescence
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
6
60
1.00
0.00
1.2
1.0
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013166) Neutrophils/100 leukocytes in Synovial fluid
6
59
1.02
0.00
1.2
1.2
%
40.0
51.9
—
6
53
(3016426) Methylmalonate [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
205.7
—
0
5
(3017569) Oxygen content in Arterial blood
7
79
0.89
0.00
1.6
2.7
—
—
—
0
0
(40758358) Immune stain study
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041678) Intrinsic coagulation system thromboelastography panel - Blood
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3034426) Prothrombin time (PT)
7
78
0.90
0.00
1.4
1.2
—
—
—
0
0
(3008640) Bordetella pertussis IgG Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003157) Bacteria [#/volume] in Mother's milk
0
5
0.00
0.00
0.0
9.0
—
—
—
0
0
(3034614) HLA Ag [Interpretation]
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3049242) von Willebrand panel - Platelet poor plasma
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3004982) Buprenorphine [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
3.0
—
1.5
—
0
5
Mortality – FinRegistry
↥Association
Association between endpoint ULCEROTH and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| ULCEROTH | 1.372 [1.22, 1.55] | < 0.001 |
| Birth year | 1.001 [0.99, 1.01] | 0.903 |
During the follow-up period (1.1.1998 — 31.12.2019), 567 out of 5349 females with ULCEROTH died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| ULCEROTH | 1.247 [1.12, 1.39] | < 0.001 |
| Birth year | 0.989 [0.98, 1.0] | 0.025 |
During the follow-up period (1.1.1998 — 31.12.2019), 815 out of 5965 males with ULCEROTH died.
Mortality risk
Mortality risk for people of age
years, who have ULCEROTH.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.097% | 0.224% |
| 5 | 0.749% | 1.434% |
| 10 | 2.112% | 3.919% |
| 15 | 4.287% | 7.111% |
| 20 | 7.497% | 12.132% |
Relationships between endpoints
↥Index endpoint: ULCEROTH – Other ulcerative colitis
GWS hits: 12
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data